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ABSTRACT 
 
 
 
With advances in fetal diagnosis and therapy, fetoscopy has become a good option to treat a series of 
life threatening diseases like twin-to-twin transfusion syndrome or severe congenital diaphragmatic 
hernia. The efficacy of fetoscopy for those types of disorders is not debatable; however, it comes with a 
daunting limitation: iatrogenic preterm premature rupture of the fetal membrane (iPPROM). The injury 
created by the instruments to access the amniotic cavity is the reason for fetal membrane rupture in 
almost one third of all interventions. The consequences of very early iPPROM are death or very preterm 
birth leading to physiological complications for the baby, and psychological burdens for the family. A 
solution preventing iPPROM is necessary to make fetoscopy a safer procedure. 
 
We first concentrated on developing a minimally invasive medical device to stabilize the fetal membrane 
defect caused by fetoscopic instruments. Our approach consists in placing bioadhesives at the wounded 
site from the inside of the amniotic cavity following the intervention. To do so, we designed and produced 
an umbrella-shape receptor whose mechanical properties enabled its crimping inside the accession 
catheter and ensured its automatic deployment inside the cavity. The umbrella is then pulled against the 
membrane and glued by gathering injectable bioadhesives. We demonstrated evidence of the 
functionality of the method by applying existing biocompatible glues on an ex vivo model replicating 
physiological conditions. 
 
While the application method is a requirement for a reliable delivery of injectable materials, questions 
remain about the nature of those materials. Restauration of the native tissue might provide functional 
advantages over the simple sealing of it. Hence, the development of platforms enabling the in vitro study 
of cell response to biological cues was the focus of the next investigations. First, we took advantage of 
the tunability of polyethylene glycol (PEG) synthetic hydrogels to locally bind growth factors (GFs) by 
affinity. We established a GF gradient in 3D and assessed multiple methods to quantify cell behaviour in 
response to those gradients. 
 
Next, we utilized a method to pre-fabricate hydrogel gradients in a full 96-well plate and established 
scripts to automate image acquisition, image processing and data analysis. This platform enabled a fast 
quantification of the influence of GF concentration on the recruitment of cells in large number of samples 
in parallel. We then reproduced a wound in a tissue model in vitro, injected PEG hydrogels carrying GF 
and quantified cell recruitment into the healing hydrogel. 
Finally, we used a proteomics approach to investigate the effect of bioactive signals on inducing a 
differential production of extracellular matrix (ECM) by the cells. This investigation was motivated by the 
critical role of ECM proteins in tissue functionality and thus by the importance of faithfully reconstituting 
the native structure of the tissue. 
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To summarize, our efforts contributed to the advancement of fetal therapy by bringing innovative 
solutions in two distinct fields. On one side, by the development of a technology to apply materials at the 
site of defect; and on the other side, by the establishment of platforms allowing the exploration of cell 
behaviour. Combined, they carry a real potential to engineer methods for precise delivery of healing-
inducing biomaterials and consequently to reduce the risks of iPPROM. 
 
 
 
 
 
 
 
 
Key words: iPPROM, fetal membranes, fetoscopy, hydrogels, 3D cell culture, wound model, gradient, 
extracellular matrix, growth factors, proteomics 
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RÉSUMÉ 
 
 
 
Avec le progrès en diagnostic et thérapie fœtale, la fétoscopie s’est avérée être une bonne option pour 
une série de maladies engageant le pronostic vital comme par exemple le syndrome transfuseur-
transfusé ou la hernie diaphragmatique congénitale. L’efficacité de la fétoscopie pour ce genre de 
troubles n’est pas questionnable, cependant, elle est accompagnée d’une importante limitation : la 
rupture prématurée iatrogène de la membrane fœtale (iPPROM). La blessure créée lors de l’insertion des 
instruments de fétoscopie dans la cavité amniotique résulte en la rupture de la membrane dans environ 
un tiers de toutes ces interventions. Les conséquences d’iPPROM précoces sont la mort ou la naissance 
très prématurée avec pour conséquence des complications physiologiques pour le bébé et un fardeau 
psyhologiques pour la famille. Une solution pour empêcher l’iPPROM est nécessaire afin de rendre cette 
procédure plus sûre. 
 
Nous nous sommes premièrement concentrés sur le développement d’un dispositif médical à invasion 
minimale afin de stabiliser la plaie sur la membrane amniotique créée par les instruments de fétoscopie. 
Notre approche consiste à placer des bio-adhésifs sur le lieu de perforation par l’intérieur de la cavité 
amniotique suivant l’intervention. Pour ce faire, nous avons designé et produit un élément en forme de 
parapluie dont les propriétés mécaniques permettent de le plier à l’intérieur du cathéter utilisé durant la 
fétoscopie et assure son déploiement automatique à l’intérieur de la cavité amniotique. Le parapluie est 
ensuite placé contre la membrane et collé à celle-ci en recueillant des bio-adhésifs injectables. Nous 
avons démontré des preuves fonctionnelles de cette méthode en injectant des colles biocompatibles 
existantes sur un modèle ex vivo reproduisant des conditions physiologiques. 
 
Alors que la méthode d’application est une qualité requise pour déposer des matériaux injectables de 
manière fiable, la nature de ces matériaux demeure un point d’interrogation. Une restauration du tissus 
naturel doit sûrement apporter des avantages fonctionnels comparé à l’unique scellage de la plaie. Pour 
ce faire, dans les investigations suivantes, nous nous sommes attardés sur le développement de 
plateformes permettant l’étude in vitro de la réponse cellulaire à des signaux biologiques stimulant le 
processus de guérison. En premier lieu, nous avons profité de la versatilité des gels de polyéthylène glycol 
(PEG) pour y attacher des facteurs de croissance par affinité. Nous avons établi un gradient 3D de 
facteurs de croissances et évalué plusieurs méthodes de quantification du comportement cellulaire en 
réponse à ces gradients. 
 
Nous avons ensuite utilisé une méthode pour pré-fabriquer des gradients d’hydrogel dans une plaque 
entière de 96 puits et avons établi des scripts afin d’automatiser l’acquisition et le traitement d’images 
ainsi que l’analyse de données. Cette plateforme a permis la quantification rapide d’un grand nombre 
d’échantillons en parallèle de l’influence de la concentration des facteurs de croissance sur le 
recrutement de cellules. Nous avons ensuite reproduit un modèle de plaie in vitro, y avons injecté des 
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hydrogels de PEG porteurs de facteur stimulant la guérison et avons quantifié le recrutement de cellules 
dans ces hydrogels injectés. 
Pour conclure, nous avons utilisé une approche protéomique afin d’enquêter sur les effets de signaux 
bioactifs dans l’induction de la production différentielle de matrice extracellulaire (ECM) par les cellules. 
Cela a été motivé par le rôle critique des protéines de l’ECM sur la fonction d’un tissus et par 
conséquence, sur l’importance de reconstituer la structure d’un tissus de manière fidèle. 
 
En résumé, nos efforts ont contribué à l’avancement de la thérapie fœtale en apportant des solutions 
novatrices sur deux plans. D’une part par le développement d’une technologie permettant l’application 
de matériaux sur l’endroit de perforation et d’autre part, par la création de plateformes permettant 
l’exploration du comportement cellulaire. Ensemble, ces éléments portent un réel potentiel pour 
l’ingénierie de méthodes permettant le placement précis de matériaux bioactifs et par conséquence 
pour la réduction des risques d’iPPROM. 
 
 
 
 
 
 
 
 
Mots clés: iPPROM, membranes fœtales, fétoscopie, hydrogels, culture cellulaire en 3D, modèle de plaie, 
gradient, matrice extracellulaire, facteurs de croissance, protéomique 
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CHAPTER 1 _ INTRODUCTION 
 
 
 
 
1.1 _ BACKGROUND 
FETAL MEMBRANES 
Fetal membranes consist of an organized multilayer system with two overlapping layers, the inner 
layer, the amnion and the outer one, the chorion. The amnion is a strong tissue of a single layer 
of epithelial cells, a basement membrane and a thick layer composed of mesenchymal cells, 
which are multipotent stromal cells having the ability to differentiate into multiple cell. The third 
layer of the amnion, composed of proteoglycan, enables it to slide over the chorion, on which it 
lies. The chorion is composed of three different layers. One of those is populated by trophoblasts, 
which are the first cells to be differentiated during development and are responsible for the 
implantation of the egg into the uterus and to strong attachment to the maternal decidua (Figure 
1.1).1,2 Each of those layers are composed of a precise combination of proteins building the 
extracellular-matrix (ECM) environment. Collagens, proteoglycans and glycoproteins are 
responsible for ensuring the structural function of the membranes by providing tensile strength, 
elasticity, anchoring functions, structure maintenance and mechanical stability.1 The 
components of those membranes have been reported to vary over time and are closely related 
to cell apoptosis followed by matrix metalloproteinase (MMP) production.3,4 The consequence of 
such MMP production is the weakening of the membrane and, along with structural changes 
caused by contractions, the spontaneous rupture of the membrane. Thus, besides its main 
function to hold the amniotic fluid and protect the foetus from adverse effects, fetal membranes 
appear to participate to a programmed self-weakening leading to the induction of labour. 
 
Figure 1.1. Schematic drawing of the structure of the fetal membranes and their 
compositions in extracellular matrix proteins at term. Figure reproduced with 
permission from  Parry et al.2, Copyright Massachusetts Medical Society 
Introduction 
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FETAL SURGERIES 
While spontaneous rupture of the membrane (ROM) is a natural process, premature rupture 
(PROM) is a complication occurring in 5-10% of all pregnancies and caused by various factors 
such as inflammation, genetics or external factors.5 With advances in fetal diagnosis and 
therapies, a new origin of membrane rupture has appeared, namely the iatrogenic preterm 
premature rupture of the fetal membrane (iPPROM). This is caused by fetoscopies, which are 
endoscopic fetal surgeries aiming to treat life-threatening anomalies on the foetus or the 
placenta during pregnancy (Figure 1.2). In opposition to open fetal surgery where the foetus is 
exposed by opening the uterus and the amniotic sac, fetoscopy accesses to the amniotic cavity 
by minimal invasion through the abdominal wall and the fetal membranes. The most common 
indications requiring fetoscopy include twin-to-twin transfusion syndrome (TTTS), severe 
congenital diaphragmatic hernia (CDH), discordant monochorionic twins with a lethal anomaly 
or reverse arterial perfusion (TRAP).6,7 Despite the good efficiency of those treatments, iPPROM 
occurs in up to 30% of all the surgeries due to the injury of the fetal membrane caused when 
punching through it when accessing the amniotic cavity. The consequence of such an event 
can be dramatic for the children suffering from it. Indeed, preterm birth carries a big risk of 
complication going from morbidity to incurable diseases decreasing life quality and/or 
expectancy such as cerebral palsy, impaired cognitive skills, vision problems, hearing problems, 
behavioural, psychological as well as chronic health issues.8,9 It is thus safe to say that iPPROM 
remains the weak spot of those interventions and a solution to prevent iPPROM could 
considerably improve the success rate of fetal treatment.10 
 
Figure 1.2. Schematic representation of a fetoscopic intervention (in this case a laser fetal 
surgery treating TTTS) taken from med.brown.edu and a magnified photo of the fetal 
membrane defect created by the puncture for accessing the amniotic cavity. Photo reprinted  
from Gratacos et al.11 with permission from Elsevier. 
 
HEALING OF MEMBRANES 
Interestingly, human fetal membranes are limited in their healing capacity and holes created by 
fetoscopy remain open after fetoscopy until the end of pregnancy.11 The reason for that is not 
yet well understood but is likely due to the lack of support matrix, innervation, vascularization and 
thus healing signals in vivo. Another reason could be the inhibition of repair mechanism due to 
MMP activity at the wounded site as observed in a mice model.12 Considerable effort has been 
made to try to close the wound in fetal membranes in order to prevent iPPROM. Many attempts 
have been made to try sealing with glues or plugs and healing with biological triggers.13 However, 
clinicians have not adopted a single of those techniques due to the lack of efficiency and/or 
Introduction 
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reproducibility of the methods. Many factors, such as the difficultly to access the wound or the 
localization of the wound, transparency and dimension (thickness of only a few hundred 
micrometres) of the membranes and wet conditions, make the study of why the healing of 
human fetal membranes does not occur, very challenging.14 
Some studies investigated healing potential in vitro of fetal membrane by cultivating membrane-
derived cells on 2D monolayers or in 3D cell cultures.15,16 Healing signals were present in a very 
limited amount17-19 but could be stimulated by the exposure to soluble epidermal growth factor 
(EGF) and insulin-like growth factor-1 (ILGF-1).13 
The healing potential of fetal membranes has also been studied in animal models. Rat models 
reported a significant reduction of wound size despite the fact that its integrity was not restored.20 
In opposition, a rabbit model showed membrane integrity restoration of up to 40% of the 
animals.12 However, none of these promising results have been observed in sheep and monkey 
studies.21 These results attest the very limited spontaneous healing of FMs and confirm the 
observations made on human fetal membranes.11 
Due to the inherent limited healing capacity of membranes, researchers have adopted a 
strategy consisting in placing cell instructive materials at the defect site to trigger wound healing. 
This has been done in rabbit mid-gestational models by inserting decellularized amniotic 
membranes where an increased reepithelization was observed when the scaffolds were inserted 
alone22, glued with fibrin23 or loaded with mixed, soluble transforming growth factor beta (TGF?) 
or fibroblast growth factor 1 (FGF-1).24 The regeneration potential of FMs by their native cells is 
thus non-questionable. Their combination with scaffolds and precise biological signals are thus 
hypothesized to be critical determinants for efficient cell recruitment, proliferation and survival, 
which are essential factors required for a potential clinical application. 
 
SEALING OF MEMBRANES 
Another approach consists in applying sealing components instead of healing-triggering 
materials. Many ex vivo studies have been conducted to try to find potential components for an 
optimal FM sealant. Materials such as fibrin glue25, platelets rich plasma26, thrombin-containing 
commercial preparations27 as well as laser welding of the membrane28 were tested. Platelets 
derivate showed good sealing potential but their use in vivo would require an appropriate 
application method. Laser welding was possible and efficient but the difficulty of its 
standardization and the risk of thermal injury discarded it from the list of candidates. 
In vivo, animal models have been used to assess fetal membrane sealing. Sealing potential was 
observed when applying fibrin glue25,29,30, collagen19 or gelatin sponges20, collagen slurry31,32 and 
Matrigel™.33 Similar attempts of applying sealing-inducing patches have been performed on 
humans. Alternatively, the use of amniopatch (mix of fibrinogen and platelets), which aims to 
reproduce the blot clot mechanism to seal the wound reported an increase in membrane closure 
and fetal survival when applied alone34,35 or in combination with fibrin.30 However, its relative 
success came along with reports of fetal death caused by excessive loss of blood.36 A lot of hope 
has been placed on these naturally derived materials due to their apparent ability to seal fetal 
membrane ruptures. However, their instability, lack of controlled effect and difficult delivery are 
reasons why they cannot be used clinically. 
Introduction 
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MUSSEL GLUE FOR SEALING APPLICATION 
A lot of work in the scientific community has focused on the development of injectable 
candidates for sealing tissues in the body. Their efficiency in a wet environment is one of the main 
requirements for the successful use of such a glue. Current approaches base their development 
on gluing mechanisms inspired by nature. The chemical properties conferring the gluing potential 
of those naturally occurring sealants are deciphered and added into synthetic material 
backbones able to carry those chemical features. For example, glues have been developed 
using the principles of geckos or worms to be used as band-aids or help wound closure inside of 
the body.37,38 Similarly, marine and freshwater mussels have also been an inspiration given their 
ability to adhere to organic and inorganic structures underwater.39-41 Proteins produced in high 
concentration at the mussel’s feet contain a catechol side chain of 2, 3-dihydroxyphenylalanine 
(DOPA) that confers this very adhesive property. This side chain was synthetically added to star-
shaped poly (ethylene glycol) (PEG) macromeres to form a catechol-functionalized PEG (cPEG) 
giving this injectable synthetic material a strong sealing potential. Crosslinking of cPEG molecules 
is triggered by the addition of sodium periodate in equal volume.42 This second precursor has a 
potential harmful action on surrounding tissues due to its strong oxidizing potential. However, the 
very quick and strong reaction with cPEG precursors might ensure rapid use of periodate and fast 
reduction into less irritating species.43 
Recent evidence has shown cPEG´s non-toxic, very good sealing potential, leak-proof closure on 
stretching models in vitro44,45 and demonstrated good promise on in vivo rabbit models.46 In 
addition, advantages over fibrin glue have been proven to reside in its potential to work under 
wet conditions in an ex vivo study.47 Its long-lasting adhesion conferred by the slow hydrolysis of 
the material definitely sets this glue as another very good candidate as a  fetal membrane sealing 
material. 
 
HYDROGELS AS 3D CELL CULTURE PLATFORMS 
A strategy used in many laboratories to mimic cell environment is the use of synthetic materials 
such as cell scaffold for 3D culture. PEG hydrogels have been widely described and have proven 
their potential to allow recreating similar environments as encountered by cells in nature.48,49 The 
ECM-mimicking structure does not only provide an adequate network for cell survival but also 
enables stiffness and degradability variation for optimal cell behaviour.50 A further advantage, 
when compared to the use of collagen or Matrigel™, is the lack of biological background, 
making all the observations inherent to the attributes conferred by gel modification.51-53 From a 
regenerative medicine point of view, this allows for the careful study of the environment formed 
by the cells in their hydrogel scaffold. This is particularly important given the structural and 
bioactive roles that ECM proteins have. Indeed, ECM-cell interaction has a central role in 
immobilizing biological cues54,55 and regulating stem behaviour and fate.52,56-61 Thus, deciphering 
the ECM protein composition can help investigate the effects of biological signals in directing 
specific protein synthesis.16,62-64 
The hydrogels used in our laboratory are based on the cross-linking of PEG substrates triggered 
by the transglutaminase enzyme factor XIII activated (FXIIIa).65,66 This enzyme catalyses the 
formation of a covalent bond between the acyl group of Glutamine and the amine group of 
Introduction 
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Lysine contained within peptide substrate domains (Figure 1.3). Adhesion sites such as RGD are 
added following the same principles. This amino acid sequence, together with a MMP-sensitive 
domain present in the linker-peptide, is essential to allow cell survival, spreading and migration.65-
67 In addition, its chemical structure permits the addition of cell instructive signals to its backbone. 
This allows a flexible and independent variation of multiple parameters towards the modification 
of the 3D cellular environment in vitro, which can have a significant influence on the cells.68-70 The 
possibility to immobilize different motifs to those synthetic gels gives rise to a multitude of options 
to tune them. For example, biological signals could be modified to possess the peptide 
recognized by FXIII and be covalently bound to the gel upon gel formation. Alternatively, the 
addition of streptavidin to the hydrogel backbone would enable the immobilization of 
biotinylated proteins thanks to the affinity that streptavidin and biotin have.71 Another option is to 
covalently bind protein A to the gel and immobilize proteins that have been modified by the 
addition of the long chain residue of antibodies, which has an affinity to protein A.72-74 Despite 
the infinite imaginable options, the challenge remains in how to organize the presentation of 
those biological cues in 3D. Indeed, while it is straightforward to add biological cues in a 
homogeneous manner inside a gel during the polymerization of it, it is challenging to immobilize 
those cues in a spatially controlled manner. 
 
 
Figure 1.3. PEG polymerization process. 8-arm PEG with Lysine end binds together with the 8-arm PEG with 
Glutamine end by enzymatic crosslinking lead by FXIIIa in the presence of Calcium ions. 8-arms Lysine PEG 
has an MMP-sensitive amino acid sequence to permit cleavage. Growth factors (GF), RGD binding 
sequence or other motifs (…) can be bound to the PEG backbone by the same mechanism. 
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ELECTROCHEMISTRY TO LOCALLY INHIBIT PEG POLYMERIZATION 
While models as described previously are very convenient to mimic tissues in vitro, they are limited 
in throughput. The dissociation of gel formation and cell seeding may enable to tackle this 
burden. The objective is to provide with higher throughput models without impairing in the 3D cell 
culture characteristics. Recent developments in the lab have used the properties of the enzyme-
mediated polymerization to this matter.75,76 The principle relies on the pH-dependency of enzyme 
activity. As schematized in Figure 1.4, FXIII works only in a defined pH window. At higher or lower 
pH, FXIII activity is inhibited and polymerization does not happen. In order to inhibit locally gel 
formation, a conductive metal placed in the gel is loaded with electric current. By water 
hydrolysis, protons are produced and the pH drops, inhibiting gel formation around the metal. 
This principle is used to form hydrogels with softness gradients. These gradients enable cell 
penetration in 3D even if they are seeded after gel formation. One important advantage of this 
method is the possibility to pre-fabricate a large number of gels prior to cell seeding and 
cultivation. 
 
 
Figure 1.4. Schematic representation of enzymatic polymerization of PEG. The transglutaminase factor XIIIa is 
active only in a certain range of pH, outside of which it does not initiate polymerization.  
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1.2 _ MOTIVATION 
Preterm birth is the leading cause of child morbidity under the age of 5. It causes approximately 
1 million deaths yearly in the world and leaves about 14 million other babies with risks of lifetime 
disabilities related to the interruption of their development in the maternal womb.77 The factors 
provoking delivery at early stages are partly known and include physiological conditions from the 
mother and/or the foetus, psychological status, medication, environment, genetics and possibly 
an overlap of those factors.78 One physiological cause of preterm birth is the preterm premature 
rupture of the fetal membrane (PPROM), which results in the induction of the delivery. PPROM 
can happen either spontaneously or following fetoscopy (iPPROM). Preventive sealing and 
stabilization of the defect created when punching the fetal membrane during fetoscopy could 
significantly decrease the risks of fetoscopy by extending the pregnancy and thus drastically 
improve fetal health and survival.79 It would on one side reduce complications encountered by 
premature babies and on the other side prevent the huge trauma experienced by parents after 
the loss of a child. Previous researchers have failed to offer an effective solution to the problem. 
Thus, this project will seek to combine expertise in various engineering domains in order to step 
towards the healing of the amniotic membrane and reduce the risks of iPPROM. 
 
 
1.3 _ SPECIFIC GOALS 
Our long-term vision consists in delivering, very precisely, at the site of puncture, a material able 
to trigger the healing and subsequent closure of the fetal membrane defect. Given the two 
distinct aspects of our approach, which is composed of a delivery system and a healing material, 
we subdivided the project into specific goals (Figure 1.5). 
 
1. To develop a minimally invasive surgical device for the application of a membrane sealant 
on an ex vivo fetal membrane injury model 
The first element of the research presented in Chapter 2 aims to develop a prototype of a 
surgical tool for the application of a bioadhesive at the site of the membrane defect. It is a 
very translational oriented goal, in which many practical aspects have to be considered. 
Application technique, glue retention strategy, materials and geometric parameters are all 
elements that have to be taken into consideration. The objective is to have a tool in hand that 
respects all the critical criteria for compatibility to actual fetoscopic instruments. The feasibility 
of the method will be evaluated by assessing the delivery efficacy of multiple glues and the 
adhesive strength on an ex vivo fetal membrane injury model developed for this study. 
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2. To rationally establish hydrogel platforms to study cell behaviour in contact with bioactive 
cues promoting tissue healing 
This aim is based on the hypothesis that fetal membranes can undergo healing upon 
stimulation with appropriate growth factors and the presence of a supportive matrix. 
First, we utilized the binding capabilities of engineered hydrogels to expose biological cues in 
a locally controlled manner in 3D. This work, presented in Chapter 3, quantifies mesenchymal 
stem cells (MSCs) response upon exposure to a stable platelet-derived growth factor (PDGF) 
gradient. 
 
In Chapter 4, we harnessed the advantage of the possibility of tailoring locally PEG 
mechanical properties to establish a method enabling the rapid quantification of cell activity 
in response to growth factors in a large number of samples simultaneously. Based on the 
findings, we developed a tissue injury model and assessed the potential of those healing cues 
to recruit cells into the wound mimic. 
 
3. To study the protein composition of the extra-cellular matrix (ECM) environment generated by 
the cells cultures in hydrogel 
Our work is based on the hypothesis that fetal membrane defects can be healed upon 
stimulation by the right bioactive cues. To restore the integrity of the injured tissue, it is relevant 
to detain means to enable the study of growth factor effect on ECM protein production. 
Chapter 5 demonstrates a proteomics approach to identify the ECM proteins present in the 
PEG hydrogels hosting MSCs stimulated by healing inducing cues.  
 
 
Figure 1.5. Scheme of the aims discussed in this work. Objective 1 focuses on the delivery method of 
materials and is presented in Chapter 2. Objective 2 focuses on the engineering of smart materials in 
vitro, which is presented in Chapters 3 and 4. Objective 3 presents in Chapter 5 a method to assess the 
ECM produced in synthetic hydrogels.  
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2.1 _ ABSTRACT 
The benefits of endoscopic fetal surgery are mitigated by the high risk of iatrogenic premature 
preterm rupture of fetal membrane (iPPROM). While previous studies have reported good sealing 
candidates to prevent membrane rupture, the delivery of these materials to the location of 
membrane puncture has not been addressed. We describe an approach to apply sealing 
materials onto the inside of the amnion through the same catheter used for the fetoscopy. We 
developed a device composed of an umbrella-shaped receptor and an applicator. The 
receptor is pushed through the catheter by the applicator and expands automatically when 
pushed into the amniotic cavity. The receptor is then positioned and glued against the amnion 
at the defect site. We tested the adhesion strength of multiple glues and tested the feasibility and 
reproducibility of this fetal membrane sealing approach on an ex vivo model. The receptor 
opened in all tests and its positioning showed no particular difficulties (n = 18). When applied via 
the minimal invasive procedure, receptors were glued efficiently onto the membrane and all of 
them completely covered the defect (n = 5). The mean time needed for the whole procedure 
was 3 minutes. This study attests of the feasibility of our method and presents a potential future 
solution for the precise local application of bioadhesives for the prevention of membrane rupture 
after fetal surgeries. 
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2.2 _ INTRODUCTION 
With advances in fetal diagnosis and therapies, in specialized centers fetoscopy has become a 
real therapeutical option to treat potentially life-threatening diseases during pregnancy. 
However, this invasive intervention into the amniotic cavity is associated with a significant risk of 
preterm birth resulting in fetal morbidity and mortality.1 Preterm birth is mainly due to the injury of 
the fetal membranes, which do not heal spontaneously after surgical injury.2-5 The risk of an 
iatrogenic preterm prelabor rupture of fetal membranes (iPPROM), which happens in up to 30% 
of all fetoscopies,1 affect a significant number of pregnant women worldwide. Therefore, it is 
generally accepted that preventive sealing and stabilization of fetal membranes could 
significantly extend pregnancy and thus drastically improve fetal health and survival. 
In opposition to reports indicating potential fetal membrane healing signals in vitro,6-8 ex vivo and 
in vivo investigations show a very limited success towards membrane healing. One approach 
showed by some studies has focused on the deposition of scaffolds to promote cell invasion and 
trigger wound healing. Decellularized amniotic membranes stimulated reepithelization on in vivo 
rabbit mid-gestational models when implanted alone9 or in combination with fibrin.10 The same 
results were observed when porcine-derived bioactive membranes were used as carriers of 
soluble transforming growth factor beta (TGF?) or fibroblast growth factor 1 (FGF-1).11 Another 
approach to seal fetal membranes consisted in inserting nature-derived materials. This was 
successfully done on animal models by applying ECM-mimicking materials such as Matrigel™12 
or by placing sponges containing collagen12 or gelatin.13 However, collagen plug insertion was 
also tested on humans but did not show any evidence of decreasing the risks of membrane 
rupture.14 
Alternatively, biocompatible materials derived from the natural blood clotting mechanism were 
used to reproduce the coagulation process in wound healing and seal the defects. Previous ex 
vivo work reported fibrin glue15 and platelet concentrate16 as potential effective amniotic 
membrane sealants. Although animal models could not confirm the efficacy of fibrin glue,17 in 
vivo studies on humans reported a relative success for amniotic fluid leakage prevention when 
platelets were added in combination with cryoprecipitate 18,19 or covered with industrially-
available fibrin glue. 20,21 Positive performances of platelets injection were accompanied with 
extensive platelet production and provoked fetal death in some reported cases. 22 
More recently, the development of mussel-inspired adhesives working in wet environments 
brought new hopes for the efficient closure of the fetal membrane.23-25 Indeed, this glue showed 
good sealing potential in vitro,24,26 ex vivo25 and on rabbit models in vivo.23 
Despite a multitude of candidate glues for membrane sealing, there is an obvious lack in a 
reliable method to deposit these sealants, which are applied in a liquid form, on the inside of the 
amniotic cavity at the exact site of injury. This study aims to establish a method to seal fetal 
membrane defects by accessing the wound through the catheter used during fetoscopy. To 
reach this aim, the focus was set on developing a minimally invasive device able to deliver a 
gluing material in a very controlled and localized manner at the site of fetal membrane puncture. 
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2.3 _ MATERIALS AND METHODS 
Our approach to prevent iPPROM relied on the combination of three elements: i) a receptor for 
the gathering of adhesive materials, ii) an applicator to introduce the receptor and iii) an 
injection system to deliver the adhesive materials inside the receptor. All these elements were 
assembled in one single device enabling to carry out the sealing procedure in five short steps. 
The idea was to insert the receptor through the fetoscopy catheter, deploy it inside the amniotic 
cavity, bring it back to the inside wall of the fetal membrane and glue the umbrella onto the fetal 
membrane. The catheter is removed while the umbrella is left glued to the membrane until it 
comes out with the baby’s birth. This method enables the sealing of the defect without 
detachment of the fetal membrane from the decidua and avoids the puncture of an additional 
hole for the application of the adhesive. 
 
 
2.3.1 _ DEVICE COMPONENTS FOR THE PREVENTIVE SEALING OF FETAL MEMBRANES 
 
UMBRELLA-SHAPED RECEPTOR FOR THE GATHERING OF SEALING MATERIALS 
The receptor is responsible to gather the sealing materials at the site of puncture and is glued 
against the fetal membrane until delivery. It was composed of two elements: a nitinol backbone 
and a membrane covering that backbone in order to gather the adhesives. Nitinol is a very 
elastic FDA approved metallic alloy that possesses unique shape memory properties.27 The nitinol 
stripes thickness was set at 200µm and the umbrella-shaped height at 3mm. The receptor was 
composed of 8 identical oval struts, each connected to the neighboring one, forming a circular 
shape. This circular design directed the tight folding of the umbrella into a shape smaller than the 
10 French catheter (Figure 2.2A). They were produced by laser cutting followed by temperature-
based shape setting. 
As for the membrane covering the nitinol backbone, Degrapol®, a polyesterurethane polymer, 
was the material of choice given its high elasticity.28 Besides its ideal mechanical characteristics, 
it has previously shown good biocompatibility and capacity to integrate into rabbit fetal 
membranes and promote reepithelialization.9 To make those membranes, we first produced 
150?m thick Degrapol® sheets. To do so, 600mg of lyophilized Degrapol® was dissolved in 3.52g 
of Chloroform and 0.88g of Hexafluoroisopropanol to make 5g of 12% Degrapol® mix. The solution 
was left at room temperature overnight and 2 ml of this solution was electro-spun at a rate of 1ml 
per hour on 12 glass slides rotating on the collector. The distance between the syringe needle 
and the collector was 10cm. The resulting Degrapol® sheets were removed from the glass slides 
by immersing in 30% ethanol. The nitinol backbone was inserted between two Degrapol® sheets 
that were pressed together to fuse them, covering the nitinol backbone. 
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APPLICATOR AND INJECTOR 
A stainless-steel tube with an outer diameter of 2.9mm and inner diameter of 2.7mm was 
designed and manufactured (Figure 2.2C, Applicator). This tube slid freely in the 10 French 
catheter and was tight enough to push the receptor (Figure 2.2C, Receptor) through the 
catheter. A double chamber tube connected to its glue injector (Duplocath 180, Baxter AG, 
Volketswil, Switzerland) from the Tisseel® glue pack was inserted into the hollow tube from the 
proximal to the distal end to ensure that the two glue substrates only merge at the distal end of 
the tube into the receptor. The proximal end (Figure 2.2C, Glue Injector) permitted the separate 
injection of the two glue precursors. 
The receptor must remain attached to the applicator in order to prevent the loss of it in the 
amniotic cavity upon deployment and to allow the pulling against the fetal membrane defect. 
To do so, we attached a thread to the umbrella-shaped receptor and connected it to a locking 
system at the distal part of the applicator. Upon unlocking of this system by the user, the thread 
is set free and the receptor detached from the applicator. 
 
BIOADHESIVES 
To test the fetal membrane sealing procedure Histoacryl® (B.Braun Surgical AG, Melsungen, 
Switzerland), fibrin glue (Tisseel®, Baxter AG, Volketswil, Switzerland), and mussel glue29-33 were 
employed. Histoacryl® is a cyanoacrylate-based, Federal Drug Adminitration (FDA) approved 
one component glue that polymerizes upon contact with hydroxyl ions present in wet 
environments. Due to its strong gluing ability, it is used for application such as net fixation for 
inguinal hernia.34 Histoacryl® was directly transferred from its ampoule to a syringe tube before 
application. Fibrin is another commonly used tissue sealant that showed potentially good binding 
ability to fetal membranes.26 Fibrin glue is composed of two human plasma derived precursors, 
sealer protein (mostly fibrinogen) and thrombin, which are injected simultaneously inside the two-
chamber injector tube and polymerize within 5 seconds when gathered in the receptor. The 
mechanism of action replicates the wound healing process where thrombin activates the 
coagulation cascade. Mussel glue is a sealant that readily polymerizes upon mixing of the 
polymer precursor with its activator and was shown to have very good properties for the sealing 
fetal membranes under wet conditions.25,26 As previously described, the polymer substrate is 
dissolved in 2x PBS and mixed in a 1:1 volume ratio to 12mg/ml sodium periodate for a final mussel 
glue concentration of 150mg/ml. 
 
HUMAN FETAL MEMBRANES 
Human fetal membranes were collected from patients with written consent following the decision 
from the Ethical Committee of the District of Zürich (study Stv22/2006). Fetal membranes were 
harvested after caesarian section at term (between 37 and 39 weeks) and frozen at -80°C until 
usage. All of them were negatively selected for HIV, hepatitis B, diabetes mellitus, chlamydia, and 
streptococcus B. 
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2.3.2 _ MECHANICAL TESTING 
MECHANICAL STABILITY OF THE RECEPTOR  
The mechanical stability of the receptor was assessed by measuring the force needed to 
completely flatten the receptor. A thread was attached to the center culm of the receptor with 
its hollow part facing down. The thread was then pulled until the receptor was flattened and the 
force needed to do so was measured with a dynamometer (Pesola AG, Schindellegi, Switzerland, 
ref.DO29/FH27). Receptors with and without Degrapol® membrane were pulled on solid (Petri 
dish) and soft surfaces (1.5cm thick bovine muscle) (n=5). 
 
ADHESION STRENGTH PROVIDED BY BIOADHESIVES TO GLUE THE RECEPTOR TO INTACT FETAL 
MEMBRANES 
Intact, dry fetal membranes were flattened on a Petri dish with the amnion facing up. The 
receptors were placed on top of the membrane followed by the injection of 500?l of adhesives 
inside the receptors through a syringe and allowed to polymerize for 5 min. The adhesion strength 
between fetal membrane and receptors provided by the glues was measured with a 
dynamometer by pulling the receptors perpendicularly to the membrane surface (n=5 for each 
adhesive). 
 
 
2.3.3 _ APPLICATION AND GLUING OF RECEPTOR ON PUNCTURED FETAL MEMBRANES 
 
DRY EXPERIMENTAL CONDITIONS 
A fetal membrane was mounted onto an empty plastic cup with the amnion facing downward 
to the interior of the cup. A very high bonding elastomeric membrane (3M AG, Rüschlikon, 
Switzerland) was punched with a 6mm diameter biopsy punch and deposited onto the fetal 
membrane on the plastic cup model. To quantify the mechanical stability, we measured the 
force needed to pull up the centre of the mounted fetal membrane by 1.5cm with a 
dynamometer. 
 
COMPLETE EX VIVO FETAL MEMBRANE DEFECT MODEL 
To simulate the intervention, we created a physiologically relevant ex vivo model. Porcine skin 
containing a small muscle layer with a total thickness of 0.5cm was chosen to mimic the upper 
abdominal wall. A bovine muscle of 1cm thickness and a human fetal membrane were added 
under the abdominal wall mimic to reproduce the uterus layer. Those two layers, together with 
the human fetal membranes, were put together, stretched, placed onto an 8cm diameter 
aluminum cylinder and tightly clamped by screwing a ring on top (Figure 2.1). A 5mm cut was 
made with a scalpel on the skin mimic to facilitate the access to underlying tissues. To quantify 
the mechanical stability, we measured the force needed to pull up the center of the model by 
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1.5cm with a dynamometer. The construct was watertight and had a transparent bottom for 
visualization purposes. Two inlets in the cylinder enabled the cylinder to be filled with solutions 
reproducing the amniotic fluid. Another inlet permitted the insertion of a video-intubation system 
(Acutronice Medical Systems AG, Switzerland) to enable visual control over the placement of the 
receptor. The time needed for each step of the procedure was measured. 
 
DEFECT SEALING 
A 10 French catheter (Check-Flo Performer® Introducer, Cook Medical, Bloomington, IN, USA) 
was mounted on the obturator (Anklin AG, Switzerland) and inserted through the tissue mimic in 
a 45° angle. The obturator was removed and the catheter left in the defect. The receptor was 
tightly folded and inserted in the catheter before pushing it in the plastic cup or inside the cavity 
filled with saline solution. The receptor was pulled against the membrane and 500µl of mussel 
glue, fibrin glue or Histoacryl® (100µl corresponding to the dead volume of the double-chamber 
injection channel plus 400µl adhesive) was perfused through the injector into the receptor using 
syringes connected to the injection inlets. Polymerization was allowed for 1 minute while the 
receptor was held against the fetal membrane in its umbrella-shaped conformation. After the 
intervention, membranes were unmounted from the plastic cup or the aluminum and turned 
upside down. The umbrella was pulled perpendicularly to the membrane surface and the force 
needed to remove the receptor from the membrane was measured with a dynamometer. 
 
 
 
Figure 2.1. Ex vivo fetal membrane model. A) side view B) 
top view and C) bottom view of the tissue clamped in the 
aluminum cylinder. (Scale bars: 5cm)  
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2.4 _ RESULTS 
 
2.4.1 _ DESIGN OF DEVICE FOR THE PREVENTIVE SEALING OF FETAL MEMBRANES 
To prevent loss of sealing material in the amniotic cavity, which are initially liquid and become 
solid upon curing, we developed an umbrella-shaped glue receptor (Figure 2.2A, B and C 
Receptor) that ensures local gathering of gluing materials and a shielded environment for their 
adhesion. In addition, we designed and fabricated an applicator (Figure 2.2C, Applicator) 
facilitating the application of the umbrella and the injection of the adhesives (Figure 2.2C, Glue 
injector). 
 
 
 
Figure 2.2. Photographs of the device’s components. A) top and B) side view 
of the umbrella-shaped receptor without (left) and with (right) Degrapol® 
membrane coverage. (Scale bars: 5mm) C) Applicator device prototype in its 
open conformation. The Applicator is responsible to push the Umbrella inside 
the 10 French introducer (not shown). The Glue injector is the entry site for the 
glue, which is delivered to the Umbrella with the assistance of a double 
chambered tube placed inside the Applicator (Scale bar: 15mm). The release 
mechanism of the Umbrella is controlled by one small metallic wire going 
through the Applicator (Lock). When in the Locked position, the wire traps the 
suture wire connected to the umbrella. When in the Unlocked position, the 
suture wire is no longer trapped and the umbrella can be unconnected from 
the Applicator. (Scale bar: 2cm) 
 
As the central part of the strategy explained here, the receptor was designed such that it fits 
through the catheter, deploys into a larger, predefined shape, gathers the adhesive at the site 
of defect and remains glued to the amnion until delivery. To this end, we adopted a circular 
structure made of nitinol (Figure 2.2A and B), whose form enables the tightly folding into the 
catheter and spontaneous deployment into the original shape upon exit of the catheter. This 
metallic backbone was integrated into an elastic Degrapol® membrane (Figure 2.2A and B, 
white membrane) to confine the adhesives inside the receptor and limit the exchange with the 
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amniotic fluid. Additionally, to enable the surgeon to feel a resistance before its flattening or even 
everting, the receptor was given a curvature of 3mm. The applicator, by which the receptor is 
pushed through the catheter into the amniotic cavity, is made of a tube with an outer diameter 
(3mm) and a length exceeding the catheter’s size by 10mm. The applicator was shown to slide 
through the 10 French catheter with minimal force (0.2N ± 0.02N) and access the inside of the 
amniotic cavity. 
We compared the resistance of receptors with or without Degrapol® to evaluate the contribution 
of the membrane to the receptor’s stability. In addition, we performed this assay on a plastic Petri 
dish or on a 1.5cm thick muscle layer, which aims to determine the impact of the support on 
which the receptor is measured. While the backbone on the stiff and the soft surface deformed 
at almost identical forces of 0.21 ± 0.02 N and 0.2 ± 0.02 N, respectively, the resistance to 
deformation of the full umbrella was significantly increased on both soft and stiff substrates (Figure 
2.3). The force for flattening was significantly higher on the solid substrate (0.33 ± 0.02N) as 
compared to the soft substrate (0.25 ± 0.02N). This indicates that the receptor needs to be tested 
with the membrane on a soft tissue to ensure the relevance of the assay for its in vivo application. 
 
 
 
Figure 2.3. Shape stability of the receptor. A) Umbrella-shaped receptor with with 
Degrapol® membrane on porcine muscle (soft surface) before pulling test and B) 
during pulling test. (scale bar: 5mm) C) Forces needed to flatten the receptor. (n=5; **: 
p<0.02) 
 
 
2.4.2 _ ADHESION STRENGTH OF THE RECEPTOR TO INTACT FETAL MEMBRANES 
In the first step, we evaluated the potential of three adhesive candidates to glue the Degrapol® 
coated receptors to dry, intact fetal membranes. The measured adhesion forces of the receptors 
to the fetal membranes showed that mussel glue reached similar gluing properties as Histoacryl® 
(0.83 ± 0.2N and 1.1 ± 0.17N respectively, n=5), while Fibrin with 0.2 ± 0.14N (n=5) exhibited very 
weak binding (Figure 2.4, black bars). As a drawback, Histoacryl® had the effect of drying out 
both the fetal and Degrapol® membranes. 
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2.4.3 _ APPLICATION AND GLUING OF THE RECEPTOR ON FETAL MEMBRANE DEFECTS UNDER DRY 
EXPERIMENTAL CONDITIONS 
Next, we assessed the reliability of our method in dry experimental conditions in the plastic cup 
model. We used our device to insert the umbrella and deliver the adhesives to glue the receptor 
on the fetal membrane defect. In all the assays, the receptors adhered to the fetal membrane 
following adhesion and release. However, all the glues showed different strengths of adhesion. 
Histoacryl® resisted up to 0.96 ± 0.38N (n=3) of pulling force until detachment, compared to 0.35 
± 0.12N (n=5) and 0.17 ± 0.18N (n=5) for mussel glue and fibrin respectively (Figure 2.4, grey bars). 
In all the cases (n=13), the umbrellas deployed to their initial shape, were placed tightly on the 
fetal membrane and no leakage of the glue was observed upon injection. In addition, the 
measure of mechanical stability of the model showed a force of 0.1N for a displacement of 
1.5cm. 
 
 
 
 
Figure 2.4. Gluing of umbrellas to fetal membranes. A) The 
histogram shows adhesion strengths of umbrellas glued to fetal 
membranes with B) Mussel glue (black n=5; grey n=5), C) Fibrin 
glue (black n=5; grey n=5) or D) Histoacryl® (black n=5: grey 
n=3). Black bars represent the cases where the receptors were 
directly glued on intact fetal membranes. Grey bars show the 
cases when the receptors were applied through the defect 
and glued on the fetal membrane under dry conditions. 
(**:p<0.02). The photos show representative images of 
umbrellas when glued to the fetal membrane defect model. 
(scale bars = 5mm) 
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2.4.4 _ FETAL MEMBRANE DEFECT SEALING PROCEDURE ON COMPLETE EX VIVO MODEL 
 
DEFECT SEALING EX VIVO 
To conclude the proof of feasibility of the approach, we simulated the defect sealing on a more 
clinically relevant model and observed the procedure from the inside of the cavity with an 
endoscopic camera (Figure 2.5). While the addition of saline solution simulated the amniotic fluid, 
the multiple layers improved anatomical resemblance and improved mechanical stability. 
Indeed, the displacement test assessing the mechanical stability showed a force of 1N required 
for the displacement of 1.5cm. Mussel glue was chosen due to its suited applicability in wet 
environments and its non-cytotoxicity. In all trials (n = 5), the receptor opened into its original 
shape and was properly placed onto the defect. The glue was well confined in all the umbrellas 
despite some observations of minimal leakage. These were mainly due to the slight permeability 
of the Degrapol® and to the excessive volume of adhesive injected. However, this never 
impaired the adhesion of the receptor to the fetal membranes. Indeed, all the receptors held 
onto the fetal membranes upon release and removal of the applicator. The adhesion strength 
gluing the receptor to the fetal membrane was in average 0.13 ± 0.04N. 
 
TIME OF PROCEDURE 
Time intervals needed for each part of the intervention are summarized in Table 2.1. Device 
application, which included tightly folding the receptor and placing it onto the fetal membrane, 
was the longest step of the procedure with an average of 1 minute and 28 ± 43 seconds. Glue 
injection time had a constant 1 minute polymerization period in all the tests, to which 27 ± 7 
seconds was needed to place the syringes on the glue injection inlets and apply the glue. Finally, 
13 ± 9 seconds were added to activate the locking system and release the receptor. In summary, 
the total average time for the whole procedure was 3 minutes and 08 seconds, which is 
insignificant compared to, for example, the 45 minutes needed for laser surgery in the case of 
TTTS. 
 
 Time [min:sec] Success rate 
Device 
application 
1:28 ± 0:43 5/5 (100%) 
Glue 
injection 
1:27 ± 0:07 5/5 (100%) 
Umbrella 
release 
0:13 ± 0:09 5/5 (100%) 
Table 2.1. Statistics of the fetal membrane sealing 
procedure on an ex vivo model. 
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Figure 2.5. Ex vivo fetal membrane defect sealing procedure. A) to E) 
illustrate the procedure from inside of the cylinder, reproducing the 
view from the amniotic cavity. A) accession of the catheter (blue 
tube) right after punching through the construct to create the defect, 
B) the white element shows the umbrella in its crimped 
comformationbeing introduced, C) deployed and D) pulled against 
the fetal membrane. E) Mussel Glue was absorbed by the Degrapol®, 
changing its color to red. The figure shows the umbrella glued onto 
the fetal membrane after dismantling. (Scale bar: 5mm).  
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2.5 _ DISCUSSION 
In this study, we developed a novel method to preventively seal fetal membrane defects by a 
minimal invasive procedure and succeeded in proving its feasibility. We demonstrated it by 
developing a model reproducing close to real anatomic conditions and by delivering gluing 
materials at the site of membrane puncture in a controlled manner, which is believed to be the 
key for efficient membrane sealing. Indeed, previous studies showing the deposition of hydrogel 
materials or blood coagulation-derived materials lacked a controlled method specifically 
designed for this matter.9,12,15-17,20,35 The deliberate choice of diverse sealing materials – two-
component glues like fibrin or the promising mussel glue23-26 and Histoacryl® – was done to 
demonstrate the compatibility of our device with materials of different natures and to highlight 
the relevance of our method for the testing of those injectable candidates. As follows, we discuss 
more in detail the elements that make the device presented here a serious option to be 
considered for the application of sealing or even healing agents at the site of fetal membrane 
puncture. 
 
RECEPTOR  
The umbrella-shaped receptor was easily folded into the catheter, slid freely through the catheter 
and always deployed automatically into the defined shape. The mechanical stability assessed 
by the pulling test against a hard or a soft surface indicated that the nitinol backbone stability 
needs to be measured with the membrane covering the metallic structure and on a soft surface 
in order to have relevant data translatable to the in vivo situation. In addition, the relatively low 
resistance force (0.25N) suggests that structural changes might be needed to increase this value 
up to a palpable resistance (0.5-1N) but without impairing the folding capability of the receptor. 
The reason for that would be to enable the surgeons to feel the moment when applying the 
receptor onto the fetal membrane. This can be done by increasing the nitinol thickness and 
varying the number of struts. 
As for the membrane covering the nitinol backbone, Degrapol® met the expectations for glue 
gathering but its use for further investigations is limited to non-cyanoacrylate glues. The use of an 
alternative solution to cover the nitinol backbone could potentially tackle this burden. For 
example, with expanded polytetrafluoroethylene (ePTFE), a FDA approved polymer used for 
example in hernia repair,36 membranes with important elastic and non-permeable properties 
could be generated, corresponding to the functional requirements of our application. This 
polymer can also be electrospun and is already used to cover nitinol stents in some applications.37 
The clinical use of ePTFE has also been done in combination with Histoacryl® sealant for ePTFE 
graft fortification,38 which speaks in favor of combining those materials in future investigations. In 
addition, Histoacryl® and other cyanoacrylate-based glues are routinely used in vivo for eyelid 
skin grafts without complications.39 Similar to ePTFE, silicone can provide equal mechanical 
properties. Its use in combination with nitinol for thoraco-amniotic or vesicoamniotic shunts makes 
it a good candidate for our application.40 However, further investigation is required to determine 
the best adhesive candidates to combine with silicone. 
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RECEPTOR ADHESION TO FETAL MEMBRANES 
We first aimed to assess the inherent ability of different glues to bind the receptors to fetal 
membranes, which is the sine qua non for their successful use to prevent iPPROM. The glues used 
in this study showed different characteristics. Fibrin was not efficient in any test and barely any 
adhesive force was measurable. Mussel glue and Histoacryl® showed a very good performance 
when glued on intact fetal membrane, which confirms the potential of those glues to be used as 
sealants on fetal membranes. When applying the glues on the fetal membrane defect models 
with the device, fibrin glue and Histoacryl® showed similar values in contrary to mussel glue, which 
had a lower adhesion strength. This was probably due to the lower mechanical stability of the 
elastomeric membrane, which did not allow pressing the umbrella against the fetal membrane 
to form a thin glue layer. Similarly to previous studies,26 Histoacryl® presented the strongest 
bonding efficiency throughout the study but the binding strength correlated with dissolution of 
Degrapol®, motivating once again its replacement with a more compatible material like silicone 
or ePTFE. 
 
PROCEDURE SIMULATION ON AN EX VIVO MODEL 
Finally, we chose the adhesive that was previously shown to have a significant potential to work 
in wet environment and did not have a destructive effect on Degrapol®. We increased the 
complexity of the assays by recreating the wet environment of the amniotic cavity inside the 
cylinder and recapitulated the abdominal and uterine wall with ex vivo tissues. This was necessary 
to increase by 10-fold the mechanical support provided by the whole tissue mimic compared to 
the elastomeric model (1N vs 0.1N), which granted the model with an increased physiological 
relevance. 
All the receptors were well positioned and played their role of glue gathering successfully. The 
measure of the strength of attachment showed relatively low adhesion force of mussel glue (0.13 
± 0.04N) but all stayed tight to the fetal membranes after receptor release. However, the data 
showing the adhesion strength of mussel glue on intact membranes in dry conditions indicates 
that mussel glue has the potential to confer strong adhesion. Different improvements might 
influence the adhesive strength. For example, a mixer could be added at the distal part of the 
applicator to pool the glue substrates better together. Alternatively, the optimization of the 
volume and/or viscosity of the adhesive could significantly help increase adhesion strength by 
improving fluid dynamics at the amnion and receptor surfaces. 
 
TIME OF PROCEDURE 
Furthermore, the whole procedure did take approximately 3 minutes, which is a determinant 
factor when adding up a step in the surgical procedure. This time span can be further decreased 
with training, experience and by starting the procedure with the receptor already tightly folded 
inside the tube, making the time factor a negligible element for the adoption of the method. 
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CONCLUSION 
We fruitfully designed and produced a functioning device facilitating the controlled deposition 
of bioadhesives for prophylactic sealing of fetal membrane defect after fetoscopic interventions. 
Our data indicates that the application method can reliably be used to precisely inject gluing 
materials and seal the punctured amnion from the inside of the cavity. This study also highlighted 
the need of an alternative material for the receptor membrane and for stronger adhesives. We 
believe that those elements can be improved in a further step with alternative materials already 
existing in the industrial field. Regardless of the adhesives used, the results proved the feasibility of 
our method to successfully place an umbrella-shaped receptor that gathers bioadhesives for the 
closure of fetal membrane defects while respecting the geometrical requirements imposed by 
fetoscopic intervention instruments. We are thus convinced that this method has a future in the 
prevention of iPPROM and opens a new horizon in prenatal treatment. 
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3.1 _ ABSTRACT 
This study aimed to take advantage of the hydrogel system enabling the binding of biological 
cues to the gel backbone to increase the spatial complexity of a 3D cell culture environment. 
The objective was to establish a stable gradient of biological signals by their immobilization in 
hydrogels containing a homogeneous cell population and see the effect of this gradient 
depending on the spatial distribution of the biological cues. The perivascular niche was taken as 
an inspiration for the establishment of growth factor gradients given that they play a key role in 
the development of blood vessels by directing mesenchymal stem cells (MSCs) towards the 
stabilization of those blood vessels. 
 
The perivascular niche is a complex microenvironment containing MSCs, among other 
perivascular cells, as well as temporally organized biochemical and biophysical gradients. Due 
to a lack of conclusive phenotypic markers, MSCs’ identity, heterogeneity and function within 
their native niche remain poorly understood. The in vitro reconstruction of an artificial three-
dimensional (3D) perivascular niche would offer a powerful alternative to study MSC behavior 
under more defined conditions. To this end, we here present a poly(ethylene glycol)-based in 
vitro model that begins to mimic the spatiotemporally controlled presentation of biological cues 
within the in vivo perivascular niche, namely a stably localized platelet-derived growth factor B 
(PDGF-BB) gradient. We show that 3D-encapsulated MSCs respond to soluble PDGF-BB by 
proliferation, spreading, and migration in a dose-dependent manner. In contrast, the exposure 
of MSCs to 3D matrix-tethered PDGF-BB gradients resulted in locally restricted morphogenetic 
responses, much as would be expected in a native perivascular niche. Thus, the herein presented 
artificial perivascular niche model provides an important first step towards modelling the role of 
MSCs during tissue homeostasis and regeneration. 
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3.2 _ INTRODUCTION 
Mesenchymal stem cells (MSCs) have recently been described to reside in perivascular niches of 
several human tissues.1, 2 The de novo formation of these niches, which consist of an endothelium 
that is surrounded by perivascular cells, such as MSCs, relies on the spatiotemporal controlled 
presentation of biological cues.3 Whereas metabolic demand, low oxygen tension, or healing 
wounds control the sprouting of endothelial cells by an elevated expression of vascular 
endothelial growth factor (VEGF),4 the mobilization of perivascular cells and their stable retention 
has been described to rely on factors released and presented from endothelial cells.5 One of 
these biological cues is platelet derived growth factor-B (PDGF-BB), which has been shown to 
promote chemotaxis, proliferation, and spreading of various perivascular cells.6 Its secretion at 
relatively large quantity by endothelial tip cells during vascular sprouting is required for 
perivascular cells to spread and proliferate along the vascular wall, initiating the indispensable 
vessel stabilization.7 Moreover, the distribution of endothelial cell secreted PDGF-BB is 
spatiotemporally controlled through its interaction with heparin sulfate proteoglycans (HSPG) of 
the extracellular matrix (ECM). The affinity binding of PDGF-BB to ECM components results in an 
altered presentation of the molecule to MSCs, which will face matrix tethered growth factors 
rather than soluble factors. In addition, continuous ECM immobilization results in creation of a 
stable PDGF-BB gradient that descends from the vessel. This gradient is in turn sensed by 
perivascular cells and steers their localized assembly along the surface of the vessel (Figure 3.1A). 
MSCs are operatively defined by their potential to differentiate into cells of the osteogenic, 
adipogenic, and chondrogenic lineage after in vitro expansion. However, the complexity of their 
in vivo localization in the perivascular niche and the lack of MSC-specific markers hamper our 
further understanding of their identity, heterogeneity, and functional role in adult tissue 
homeostasis and regeneration.8 Therefore, there is great need for three dimensional (3D) in vitro 
models, which adequately recapitulate the in vivo arrangement of cells, ECM components and 
other biomolecules of the perivascular niche. Such models would allow for elucidation of 
biological processes that control the fate and localization of MSCs in the perivascular niche 
during vessel assembly, quiescence, or injury induced activation. 
Recently, the systematic deconstruction of stem cell niches and their reconstruction under 
defined conditions has been proposed as a mean to understand individual parameters of 
complex niche signaling networks.9 Indeed, great progress has been made towards the 
development of ECM-mimicking synthetic matrices, potentially allowing for the in vitro emulation 
of stem cell niches by the generation of 3D microenvironments.9-11 Such hydrogel matrices, as 
they are based on biologically inert materials such as poly(ethylene glycol) (PEG), can be formed 
with defined stiffness and degradability. We have described synthetic, transglutaminase cross-
linked hydrogels (TG-PEG hydrogels), which are enzymatically degradable and contain the cell 
adhesion site RGD12, 13 and at low stiffness allow 3D cell adhesion, spreading and migration.14 Their 
modular design, additionally to the flexible immobilization of engineered building blocks such as 
growth factors or enzymes,15 allowed the formation of structured hydrogels by locally controlling 
the enzymatic gel formation.16 Of note, such PEG-based matrices, in contrast to biologically 
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derived materials such as the widely used MatrigelTM or collagen, are highly defined and do not 
exert any biological response, allowing the studying of cell behavior on a blank canvas.17-19 
 
Here, in order to elucidate MSC behavior during PDGF-controlled formation of the perivascular 
niche, we aimed at the creation of a 3D biomimetic model, which mimics the naturally occurring 
stable, matrix-immobilized PDGF-BB gradient, which is present in the perivascular niche. By 
placing MSCs within a 3D-structured TG-PEG hydrogel,13 we describe an in vitro bottom-up 
approach for the recapitulation of physical as well as PDGF-presenting properties of the 
perivascular niche (Figure 3.1B). In this model, we first confirmed the specific ability of soluble 
PDGF- 
BB but not VEGF121 to activate MSCs, leading to 3D morphogenetic processes such as cell 
proliferation, spreading, and migration. Furthermore, we assessed the activity of matrix tethered 
PDGF on MSCs and finally we created stable 3D PDGF-BB gradients, which resulted in 
spatiotemporal control of MSC spreading and motility, as was described during the naturally 
occurring investment of endothelium with perivascular cells. The herein described biomimetic 
niche model is a promising first step to study the role of MSCs during vascular morphogenesis, 
tissue healing and regeneration in vitro. 
 
 
Figure 3.1. Schematic representation of the perivascular niche. A) Native perivascular niche. The native 
perivascular niche is composed of endothelial cells, perivascular cells (pericytes and SMCs), MSCs and ECM 
matrix containing matrix associated and soluble cues. Endothelial cell derived PDGF-BB binds with high affinity 
to heparane sulfate proteoglycane components (HSPG) of the ECM and thereby form a stable localized 
gradient. B) Engineered perivascular niche. The engineered perivascular niche, analogous to its in vivo 
counterpart, consists of an artificial vessel, a proteolytically degradable matrix with integrin binding sites, and 
a stable gradient of PDGF-BB. The fate of MSCs can be evaluated within the defined, positional 
microenvironments. 
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3.3 _ MATERIALS AND METHODS 
CELL CULTURE 
Bone marrow aspirates were obtained from healthy donors (average age 28 y.o.) after informed 
consent during orthopaedic surgical procedures in accordance with the local ethical committee 
(University Hospital Basel; Prof. Dr. Kummer; approval data 26/03/2007 Ref Number 78/07). Cells 
were isolated as described previously12,13. Human bone marrow MSCs were cultured in minimal 
essential medium alpha (MEMalpha, Gibco Life Technologies, cat. no. 22571-020) supplemented 
with 10% (v/v) fetal calf serum (FCS, Gibco Life Technologies, cat. no. 10500), 1% (v/v) 
penicillin/streptomycin solution (Gibco Life Technologies, cat. no. 15140-122) and 5 ng/ml FGF-2 
(Peprotech, cat. no. 100-18B). For experiments, MSCs were cultured in serum-free DMEM/F-12 + 
GlutaMAXTM (Gibco Life Technologies, cat. no. 31331-028) supplemented with 1% (v/v) 
penicillin/streptomycin solution. MSCs between passages 2 and 4 were used for all of the 
experiments. 
 
PREPARATION OF TG-PEG HYDROGELS 
Matrix metalloproteinase (MMP)-sensitive TG-PEG hydrogels were prepared as described 
previously.21 In brief, eight-arm PEG precursors containing the pending factor XIIIa substrate 
peptides glutamine acceptor (n-PEG-Gln) or lysine donor with an additional MMP-sensitive linker 
(n-PEG-MMPsensitive-Lys) were mixed stoichiometrically (final dry mass content 1.5%) in Tris-Buffer (50 
mM Tris, pH 7.6) containing 50 mM calcium chloride. 50 ?M Gln-RGD peptide and indicated 
amounts of Gln-ZZ were added to the precursor solution prior to initiation of cross-linking by 10 
U/ml thrombin-activated factor XIIIa and vigorous mixing. 
 
MICROTISSUE FORMATION 
For microtissue formation, indicated cell suspensions (final. conc. 25’000 cells/ml) were suspended 
in the respective medium for the experiment and supplemented with 0.2% (w/v) methyl cellulose 
(Sigma-Aldrich, cat. no. M0512). Droplets of 30?l were placed in non-adhesive cell culture dishes 
(Greiner bio-one, cat. no. 633180) and cultured overnight as hanging drops. The resulting 
spheroids (approx. 750 cells) were harvested in cell culture medium and washed once with cell 
culture medium. 
 
ENCAPSULATION OF SINGLE CELLS AND MICROTISSUES IN TG-PEG HYDROGELS 
For encapsulating single dispersed cells or microtissues in TG-PEG gels, cell or microtissue 
suspensions were diluted in the respective medium and added to the complete TG-PEG solution. 
To form disc shaped hydrogels of approximately 5 mm diameter, 20 ?l of this mixture were then 
sandwiched between sterile hydrophobic glass microscopy slides (obtained by treatment with 
SigmaCote, Sigmacote, Sigma-Aldrich, cat. no. SL2) separated by spacers (ca. 1 mm thickness) 
and clamped with binder clips. To prevent sedimentation of cells or microtissues, the forming 
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matrices were slowly rotated at room temperature (RT) until the onset of gelation and then 
incubated for additional 30 min. at 37°C. The hydrogels were thereafter released and transferred 
into a 24-well plate. Finally, the plates with the gels were incubated in 500 ?l of the respective 
medium at 37°C and 5% CO2 in a humidified atmosphere.  
 
CELL LABELING 
After the experiments, the samples were fixed with 4% paraformaldehyde. After stopping the 
reaction with 0.1 M Glycine in PBS (phosphate buffered saline, pH 7.2), the samples were washed 
twice with PBS. Permeabilization was performed for 20 min at RT with 0.2% Triton X-100 (Sigma-
Aldrich, cat. no. T-8787) in PBS followed by 2 washing steps with PBS. For F-actin staining, the 
samples were incubated over night at 4°C with rhodamine-labeled phalloidin (Life technologies, 
cat. no. R415). Afterwards, the samples were washed 3 times with PBS and stained for cell nuclei 
using Hoechst (1:1000, Life technologies, cat. no. H3570). Subsequently, the samples were washed 
again 3 times with PBS before analysis with either confocal laser scanning microscopy or 
fluorescent microscopy.  
 
MICROTISSUE MIGRATION ASSAY 
MSC microtissues were encapsulated in TG-PEG hydrogels (final conc.: approx. 250 microtissues 
ml-1) and cultured for 20 hours. The samples were fixed and stained for F-actin. Z-stack images of 
microtissues were acquired at 10 x magnification using a confocal microscope (Leica TCS SP5). 
Cell migration was quantified by an automated image analysis script written in MATLAB (R2013a, 
MathWorks Inc, USA) that measures the distance of stained pixels from the microtissue center. 
Data is displayed as histogram depicting the amount of pixels relative to the migration distance. 
Pixels with a distance larger than 100 ?m from the spheroid center were considered in the 
statistical analysis. 
 
SINGLE CELL PROLIFERATION, SPREADING, AND MIGRATION ASSAYS 
MSCs were embedded in TG-PEG hydrogels (final conc.: 0.5 x 106 ml-1) and cultured for 5 days. 
For migration assays, three random positions were selected using an inverted microscope (Leica 
DMI6000 B) equipped with a motorized focus and stage. Cell migration was followed for 22.5 
hours using the manual tracking plugin in ImageJ. For proliferation and spreading assays, after 
cell fixation, cells were stained for nuclei as well as F-actin and Z-stack images (total stack size: 
500 ?m) were acquired at 10 x magnification using a confocal microscope (Leica TCS SP5). Cell 
proliferation was analyzed by measuring the numbers of 3D F-actin using the ImageJ plugin 
‘Object Counter3D’. For circularity ratio, a Z-stack projection from F-actin Z-stack images (total 
stack size: 150 ?m) was made and cell circularity ratio was calculated using ImageJ. Cell 
circularity ratio is the ratio between a cell’s shape and a circle with the same perimeter. It 
therefore is a dimensionless number that is greater than 0 and less or equal to 1. The more 
elongated a cell is the closer the circularity ratio is to 0. Cells with a circularity ratio below 0.25 
were considered as elongated. 
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PREPARATION OF THE PDMS FRAMES 
Polydimethylsiloxane (PDMS) frames were made as described previously.16 In short, the silicon 
elastomer and the curing agent (Sylgard 184, Dow Corning Corporation, USA) were mixed (10:1 
in mass) at 2000 rpm for 3 min in a ARE-250 mixer (Thinky Corporation, Japan). The mixture was 
subsequently poured into poly(methyl methacrylate) (PMMA) molds, where 500 ?m in diameter 
stainless steel wires were positioned to create the holes for the future electrodes. The mixture was 
subsequently degassed for 30 min in a vacuum chamber and baked for 4 h at 60°C. The stainless 
steel wires and the PDMS forms were removed from the PMMA molds, rinsed with isopropanol 
(IPA), oxygen plasma cleaned (1 min at 300 W, Plasma-System 100, Technics Plasma GmbH, 
Germany) and finally pressed onto plasma cleaned microscope glass cover slips. Straightened 
Tungsten wires (W, 500 ?m in diameter, Advent Research Materials Ltd, UK) were inserted in the 
PDMS forms and connected to a potentio-galvanostat in a two electrode setup (PGU-10V-1A-
IMP-S and ECMwin computer interface, Elektroniklabor Peter Schrems, Germany). 
 
RECOMBINANT PROTEINS 
Untagged growth factors were purchased from Peprotech (VEGF121, cat. no. 100-20A; PDGF-BB, 
cat. no. 100-14B). Linker protein Gln-ZZ was recombinantly produced in E.coli Bl21 as described 
previously.25 Fc tagged PDGF-BB (PDGF-BBFc) and VEGF-A (VEGF-AFc) were cloned, expressed 
and purified as follows: PDGF-B and VEGF-A from Homo sapiens (PDGF-B: NP_002599.1, aa: 21-
190 and VEGF-A: NP_001020539.2, aa: 207-371) were cloned into a modified PCEP vector with an 
N-terminal double Strep- tag II fused followed by Igh protein from Mus musculus (AAH03435.1, aa: 
245-463). A pool of HEK293 cells were stably transfected followed by screening for high level 
expression. Secreted PDGF-BBFc and VEGF-AFc were purified by Streptavidin beads (IBA). The 
purified PDGF-BBFc and VEGF-AFc were then dialyzed against 1 x phosphate buffer saline (PBS) pH 
7.4. Labeling of PDGF-BBFC was done using DyLight 550 Fluorophore (Thermo Fisher Scientific Inc.) 
following the manufacturer’s instructions. 
 
SOLID PHASE BINDING ASSAY BETWEEN GLN-ZZ AND PDGF-BBFC 
Gln-ZZ peptide was coated at 10 ?g ml-1 (500 ng well-1) overnight at 4°C onto 96-well plates (Nunc 
Maxisorb). After washing with TBS, plates were blocked for 2 hours at RT with TBS containing 3% 
bovine serum albumin. Ligand (PDGF-BBFc) was diluted to concentrations from 0.03 nM to 500 nM 
and incubated for 2 hours at room temperature. After extensive washing with TBS, bound ligands 
were detected with a streptavidin horseradish peroxidase (HRP)-conjugate (IBA) 1:5000. HRP was 
detected by Pierce TMB ELISA Substrate (Thermo Scientific™). Absorption was measured at 450 
nm after stopping the reaction with 2 M sulfuric acid. A Blank value corresponding to BSA coated 
wells was automatically subtracted. 
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CHANNEL AND PDGF GRADIENT FORMATION IN TG-PEG HYDROGELS 
Perfusable channels with a diameter of 500 ?m were produced in TG-PEG hydrogels as described 
previously.16 Briefly, 60 ?l of complete TG-PEG hydrogel mixture, if indicated, containing MSCs 
were poured before the onset of gelation into the PDMS frame accommodating a straightened 
Tungsten wire. The polymerization of the TG-PEG was allowed to progress during 6 minutes while 
the Tungsten wire was anodically polarized (2 V DC, versus a Platinum auxiliary electrode). 
Subsequent removal of the anodically polarized Tungsten wires lead to reproducible formation 
of regularly shaped channels within the TG-PEG gel. Stable or evolving PDGF gradients were 
formed by perfusing the channel with 1 ?l PDGF-Fc or fluorescently labeled PDGF-Fc (180 ng ?l-1) 
in presence or absence of 20 ?M Gln-ZZ in the surrounding TG-PEG gel, respectively. Images of 
fluorescently labeled PDGF-BBFc gradients were taken after 0.5, 24, and 48 hours using an inverted 
fluorescence microscope (Leica DMI6000 B). Fluorescence intensity was measured on a line 
perpendicular to the channel using the PlotProfile function in ImageJ 
 
ANALYSIS OF MSC SPREADING AND MIGRATION WITHIN PDGF-BB GRADIENTS 
MSCs were encapsulated in TG-PEG hydrogels (final conc.: 0.5 x 106 ml-1) within the PDMS mold 
and cultured overnight. The day after, Tungsten wires were removed and indicated amounts of 
PDGF-BBFc were loaded into the channel. For migration assays, two positions adjacent to the 
channel and two positions 3 mm away from the channel were selected using an inverted 
microscope (Leica DMI6000 B) equipped with a motorized focus and stage. Cell migration was 
followed for 22.5 hours using the manual tracking plugin in ImageJ. For spreading analysis, cells 
were fixed after 48 hours in culture. After F-actin staining, Z-stack images (total stack size: 150 ?m) 
of the complete constructs were acquired at 10 x magnification using a confocal microscope 
(Leica SP5) equipped with a long distance 10 x objective. Z-stack projections were made thereof, 
stitched together and the image was divided into 8 equally sized segments each having a width 
of 0.5 mm. For quantification, cell circularity ratio was analyzed in each part using ImageJ. 
 
STATISTICAL ANALYSIS 
All mean values were compared by one-way analysis of variance (ANOVA) using MATLAB 
(R2013a, MathWorks Inc, USA) followed by a tukey-kramer post hoc test to judge statistical 
significance. Statistical significance was accepted for p < 0.05. One asterisks reports p < 0.05 and 
two asterisks p < 0.01. 
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3.4 _ RESULTS 
 
3.4.1 _ PDGF-BB MODULATES 3D MSC FUNCTIONS IN VITRO 
In order to study the role of PDGF-BB on MSC during morphogenesis in the perivascular space, 
we established a 3D microtissue-based in vitro assay. 
MSC microtissues were embedded within a recently developed polyethylene glycol (PEG) 
hydrogel, termed ‘TG-PEG hydrogel’, that recapitulates biochemical and biophysical properties 
of the microenvironment MSCs face in their anatomical location.12, 13 This synthetic hydrogel was 
formulated to be matrix MMP-1-degradable, have low cross-link density (94 ± 25 Pa shear 
modulus)14 and provide cell adhesion sites (50 ?M RGD) in order to provide the MSCs a hydrated 
microenvironment in which proliferation, spreading and migration are possible. 4 hours after 
stimulation of the MSC microtissues with PDGF-BB already, MSCs started to migrate from the 
microtissues into the surrounding synthetic environment. Quantification of migration showed that 
in absence of PDGF-BB cells remained in a quiescent state within the microtissue, whereas upon 
20 hours of exposure to PDGF-BB (10 nM) cells had invaded the artificial ECM up to 500 ?m (Figure 
3.2A and B). When MSC microtissues were treated with equal amounts of VEGF121 no significant 
outgrowth was observed as compared to the controls. Taken together, this data confirmed that 
PDGF-BB specifically controls morphogenesis related functions of MSCs and that its role can be 
studied in vitro within the designed artificial environment. 
 
 
Figure 3.2 PDGF-BB induces 3D MSC morphogenesis in biomimetic microenvironment. MSC 
microtissues consisting of approx. 750 cells were embedded in synthetic matrices and stimulated 
with the indicated growth factor for 20 hours under serum-free conditions. A) Z-stack projections 
of F-actin stained MSCs (upper panels, scale bar = 200 ?m). Histograms showing the distribution of 
MSCs from microtissue center when stimulated with the respective growth factor (lower panels). 
C) Bar graph illustrating the percentage of actin-stained pixels being located at a distance larger 
than 100 ?m from the centre of the microtissue. Data is depicted as mean ± SD (n ? 4, **, p < 0.01, 
n.s., not significant). 
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DISCRIMINATION OF 3D MORPHOGENETIC PROCESSES BY SINGLE CELL ASSAY 
To elucidate the effect of PDGF-BB on individual cellular processes, single dispersed cells were 
embedded in TG-PEG hydrogels and cultured for several days in the absence or in the presence 
of 10 and 50nM PDGF-BB. Confocal images (z-stacks) of cytoskeleton stained cells after 5 days of 
culture revealed that presence of PDGF-BB had a dose dependent effect, which resulted in the 
formation of relatively dense cellular networks (Figure 3.3A). Automated quantification of 
confocal images was applied to analyze cell number, cell circularity ratio as a measure of cell 
elongation, and single cell migration. PDGF-BB enhanced MSC numbers on average by 45% 
(10nM PDGF-BB) and 81% (50nM PDGF-BB) (Figure 3.3B). Moreover, MSC Population’s cell 
elongation was shifted towards more spread cells with a smaller cell circularity ratio after 
treatment with PDGF-BB (Figure 3.3C). Based on the evaluation of the cell populations’ circularity 
ratio histograms, a cell that had a circularity ratio below 0.25 was considered as elongated. In 
the untreated cell population only 13 ± 4% of the cells were elongated whereas in the PDGF-BB 
treated conditions 32 ± 9% (10 nM PDGF-BB) and 63 ± 5% (50 nM PDGF-BB) of the cells were 
elongated (Figure 3.3D). Also, cell motility was increased in a dose dependent manner as found 
by tracking cells for 22.5 hours (Figure 3.3E). Whereas the mean distance that cells migrated 
during this time in the control sample was 47 ± 11 ?m, cells that were exposed to 10 nM or 50 nM 
PDGF-BB migrated 173 ± 20 ?m or 246 ± 14 ?m, respectively. Taken together, this data indicates 
that PDGF-BB is an important player in influencing multiple facets of MSC morphogenesis. 
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Figure 3.3 PDGF-BB induces proliferation, spreading and migration of 3D encapsulated MSCs. MSCs 
were encapsulated in TG-PEG hydrogels (0.5 * 106 cells ml-1) and cultured under serum-free 
conditions in presence of the indicate amounts of PDGF-BB A) Z-stack projections (total stack size 
500 ?m) of F-actin stained MSCs after 5 days of culture (scale bar = 200 ?m). B) MSC numbers as 
analysed by counting connected F-actin objects in 3D by an automated image analysis script as 
described in materials and methods. C) Histogram depicting the MSC population’s circularity ratio 
(4?*(cell area)/(cell perimeter^2)). D) Bar graph depicting percentage of elongated cells. Cells with 
a circularity ratio below 0.25 were considered as elongated. E) Cell tracks of MSCs were acquired 
and overlaid with a common starting point. The tracks represent a period of 22.5 hours (18 x 75 min) 
starting 24 hours after first growth factor exposure. F) Bar graph depicting mean migration distance. 
Data is depicted as mean ± SD (n ? 4, *, p < 0.05, **, p < 0.01, n.s., not significant). 
 
MATRIX-MEDIATED PRESENTATION OF PDGF-BB 
In order to mimic the naturally occurring interactions between the ECM and PDGF-BB and to 
control the spatiotemporal distribution of PDGF-BB within the in vitro niche model, a PDGF-BB 
variant (PDGF-BBFc) was genetically engineered such that it contains the fragment crystallizable 
(Fc) region of antibodies at its N-terminus. When combined  with a recently developed 
bifunctional linker protein (Gln-ZZ)15 this allows for mimicking the affinity interaction that is 
occurring in vivo between heparin sulfates of the ECM and PDGF-BB. Gln-ZZ can be incorporated 
into the TG-PEG hydrogel backbone via its C-terminal domain (Gln) and has high affinity for Fc-
tagged proteins through its N-terminal Z domains. PDGF-BBFc binding to Gln-ZZ and biological 
activity as well as specificity was confirmed in a solid-phase binding assay and microtissue 
morphogenesis assay, respectively. 
In order to show that matrix-immobilized PDGF-BBFc is biologically active, microtissues were 
embedded in TG-PEG gels containing 0 ?M or 20 ?M Gln-ZZ linker as well as 0, 10 or 50 nM PDGF-
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BBFc. The large excess of Gln-ZZ molecules present in the hydrogels assures that the majority of 
PDGF-BBFc molecules are present in their matrix immobilized form. As for the soluble variant, the 
matrix-immobilized PDGF-BBFc triggered MSC morphogenesis related functions, which can be 
modulated in a dose dependent manner (Figure 3.4A).  MSCs exposed to hydrogels containing 
20 ?M Gln-ZZ linker fully remained in the microtissue, with as little as  3% of actin stained areas 
(pixels) belonging to cells that had left the microtissue. On the other hand, cells that were 
exposed to hydrogels containing 20 ?M Gln-ZZ linker and 10 nM and 50 nM PDGF-BBFc showed 
respectively 41% and 67% of actin stained pixels detached from the microtissue (Figure 3.4B). 10 
nM PDGF-BBFc admixed to the Gln-ZZ free hydrogel showed similar activity as 10 nM ZZ-
immobilized PDGF-BBFc. 
 
 
Figure 3.4 MSC migration in synthetic PDGF-BB-presenting cell-instructive matrices. MSC microtissues consisting 
of approx. 750 cells were encapsulated in TG-PEG hydrogels containing 0  ?M (black) or 20 ?M (grey) Gln-ZZ 
and 0, 10, or 50nM PDGF-BBFc. A) Representative CLSM Z-stack projections of F-actin stained MSCs cultured 
for 20 hours under serum-free conditions. (scale bar = 200 ?m). B) Histograms showing the distribution of MSCs 
from microtissue center when embedded within the indicated matrix. C) Bar graph shows the percentage of 
actin-stained pixels being located at a distance larger than 100 ?m from the centre of the microtissue. Data 
is depicted as mean ± SD (n ? 3, **, p < 0.01). 
 
3.4.2 _ MICROFLUIDIC APPROACH FOR THE CREATION OF 3D PDGF-BB GRADIENTS IN PEG HYDROGELS 
As opposed to traditional cell culture assays, biomolecules within the body are not present in 
uniform concentrations, but rather in concentration gradients that descend from the site of 
biomolecule expression.21 In order to mimic in vitro the 3D PDGF-BB gradient that occurs in the 
perivascular niche around blood vessels, we applied a recently developed electrochemistry-
based technique to form artificial vessels in the middle of the hydrogel by spatially inhibiting 
hydrogel polymerization.16 Such channels were loaded with controlled amounts of PDGF-BBFc, 
which could freely diffuse from the channel into the surrounding hydrogel and reach the MSCs 
(Figure 3.5A). To monitor PDGF-BB diffusion into MSC containing hydrogels, fluorescently labeled 
PDGF-BBFc was loaded in a channel and its distribution in the gel was analysed. After 48 hours the 
PDGF-BBFc gradient had leveled out and PDGF-BBFc was almost homogenously distributed within 
the hydrogel (Figure 3.5B). In order to fabricate a more sophisticated model that takes into 
account the interaction of PDGF-BB with the ECM, we made channels in Gln-ZZ containing 
hydrogels. 
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To test if the before described interaction between PDGF-BBFc and Gln-ZZ would indeed lead to 
the establishment of the graded 3D immobilization of PDGF-BB, we perfused the fluorescently 
labeled PDGF-BBFc through the channel into the Gln-ZZ presenting and MSC containing hydrogel 
(Figure 3.5C). 48 hours after perfusion, a stable 3D PDGF-BBFc gradient originated from the 
channel into the hydrogel, indicating a stable interaction between PDGF-BBFc and the matrix in 
presence of MSCs (Figure 3.5D). 1.5 mm from the channel the level of fluorescently labelled PDGF-
BBFc had decreased to background level.  
 
MSC MORPHOGENESIS IN EVOLVING VERSUS STABLE 3D PDGF-BB GRADIENTS 
In order to elucidate MSCs’ morphogenetic response to being exposed to evolving and stable 
gradients of PDGF-BBFc, MSCs were encapsulated in TG-PEG hydrogels containing an artificial 
vessel for biomolecule perfusion. As expected, perfusion of the channel with control medium 
without PDGF-BBFc did not lead to a morphogenetic response as shown by measuring the cellular 
circularity ratio two days after perfusion within 3 consecutive segments each spanning 1.5 mm. 
Percentage of cells that were elongated (circularity ratio < 0.25) remained around 10% in all 
segments. This coincides with the value that was previously observed for the control in the static 
condition (Figure 3.3C and D).  On the other hand, perfusion of 4 ?M PDGF-BBFc, which created 
a short-term-evolving gradient of PDGF-BBFc as shown before (Figure 3.5B), lead to cell spreading 
(decrease in circularity ratio) similarly to the previous static experiments (Figure 3.3C and D). After 
2 days, however, only minor spatial differences in cell spreading were observed due to the 
levelling out of the soluble PDGF-BBFc concentrations throughout the sample (Figure 3.6A). 
Percentage of cells that were elongated (circularity ratio < 0.25) was roughly between 20% and 
40% (Figure 3.6C), which correlated with the elongation that was seen in the static condition in 
presence of 10 nM PDGF-BB (Figure 3.3C and D). 
 
 
Figure 3.5. Hydrogel microfluidics for creation of evolving and stable PDGF-BB gradients in 
presence of cells. Scheme of PDGF-BBFc delivery to 3D encapsulated MSCs using a 
perfusable channel in standard (A) and Gln-ZZ modified (C) TG-PEG hydrogels. Hydrogel 
channels were formed by electrochemical inhibition of hydrogel polymerization as 
described previously.16  B and D) Fluorescent microscopy images showing the area 
around the respective hydrogel channels 48 hours after perfusion with DyLight 550-
labeled PDGF-BBFc (upper panel) and the corresponding grey value histograms. 
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In contrast, if a stable PDGF-BB gradient was formed by perfusion of Gln-ZZ (20 ?M) modified TG-
PEG hydrogels with 4 ?M PDGF-BBFc the morphogenetic response of encapsulated MSCs was 
locally restricted to the vicinity (0 - 1500 ?m) of the artificial vessel (Figure 3.6B). Due to the stable 
retention of PDGF-BBFc only in the first segment 20% of the cells were elongated (circularity ratio 
< 0.25) whereas cells further away were not affected by the growth factor presence (Figure 3.6C). 
Moreover, the bound growth factor was locally inducing MSC motility as shown by the cell tracks 
of cells at 0 - 1 mm versus 2.5 – 3.5 mm distance from the channel (Figure 3.6B). These results 
emphasize the role of biomolecules within complex in vitro models and even more so the 
importance of controlling them spatiotemporally by mimicking the processes occurring in nature. 
 
 
 
Figure 3.6. Evaluation of MSCs in a perivascular niche microenvironment mimicking evolving and stable PDGF-
BB gradients. MSCs were encapsulated (0.25 * 106 cells ml-1) in TG-PEG hydrogels and channels for 
biomolecule perfusion were formed by electrochemical inhibition of hydrogel polymerization. Data is shown 
for both conditions after 48 hours of culture as representative Z-stack images (total stack size 500 ?m) of F-
actin stained MSCs (Scale bar = 500 ?m). Channels in unaltered (A) and 20 ?M Gln-ZZ containing (B) TG-PEG 
hydrogel were perfused with 4 ?M PDGF-BBFc. Inlays display overlaid tracks of migrating MSCs at the indicated 
positions of the sample. The tracks represent a period of 22.5 hours (18 x 75 min) starting 24 hours after PDGF-
BBFc perfusion. C) Histogram depicting percentage of cells with a circularity ratio below 0.25 relative to 
distance to channel in gels with 0 ?M (black) or 20 ?M Gln-ZZ (grey). Statistical comparison is made between 
the two groups of each region. Data is depicted as mean ± SD (n ? 4, n.s., not significant, **, p < 0.01). 
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3.5 _ DISCUSSION 
A prevalent limitation to 2D and 3D cell culture assays has long been the lack of spatial and 
temporal control over the presentation of biomolecules, which especially for the engineering of 
complex milieus such as the stem cell niche is an evident prerequisite. We here present a 
biomimetic approach that recapitulates the localized ECM immobilization of PDGF-BB in the 
perivascular niche. By combining an electrochemistry-based hydrogel patterning approach16 
with engineering of growth factor matrix interactions and diffusion controlled establishment of 3D 
gradients, human MSCs can readily be exposed to selected micro-environmental conditions as 
would be expected to occur in the surrounding of a blood vessel. This experimental setup offers 
several advantages to existing models: i) it is based on engineered ECM with defined and tunable 
physical, chemical and biological properties ii) growth factors can be promiscuously immobilized 
via affinity interactions and thus can be loaded independently of hydrogel formation and cell 
encapsulation iii) the use of channels allows the sequential loading of multiple engineered and 
native growth factors iv) due to the transparent character of the hydrogel system, cell behavior 
can be monitored throughout the length of the experiment so that morphogenetic parameters 
can be followed and independently evaluated.  
Despite the fact that great efforts were devoted towards the development of models for studying 
cell fates in stable growth factor gradients in vitro, described approaches either do not take into 
account the three dimensionality of the microenvironment that surrounds cells in vivo22-26 or 
employ matrices with inherent biological  properties27-29.  
 To the best of our knowledge, this is the first report on the implementation of a stable growth 
factor gradient within a fully defined synthetic hydrogel matrix. Moreover, as opposed to other 
studies27-29 that show stable 3D growth factor gradients, we here describe a method that allows 
for gradient formation in presence of cells, which is not only more closely mimicking the situation 
in nature, but as well omitting material interface problems that result from pre-fabrication of the 
gradient and post-hoc seeding of the cells onto the gradient. 
VEGFs and PDGFs are known to be jointly involved in the assembly and stabilization of new 
vessels5. This was illustrated by the elimination of either VEGF signaling in endothelial cell or PDGF 
signaling in pericytes or by the deletion of either the ligands or the receptors, which has resulted 
in a largely defective development and function of vessels, leading to embryonic lethality.30-33 In 
vitro PDGFs promote the migration of multiple mesenchymal cell types such as fibroblasts, smooth 
muscle cells, and MSCs. However their role in controlling cell behavior during vessel stabilization 
has not been characterized in detail. As opposed to other studies,34 we demonstrate the specific 
in vitro induction of morphogenetic processes in hydrogel encapsulated MSC microtissues by 
soluble PDGF-BB but not VEGF.  
Importantly, the majority of expressed VEGF and PDGF molecules contain a positively charged 
C-terminal domain, which has been described to bind HSPGs of the extracellular matrix.35 In vivo 
this affinity of growth factors to the ECM limits their diffusion away from the site of production and 
likely results in the formation of relatively stable positional cues. The consequence of such ECM 
immobilized cues for the formation of functional, properly structured vascular networks has been 
impressively shown by transgenic mice which either express only VEGF-variants that lack the C-
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terminal heparin binding domain (VEGF121) or only have high affinity for heparin (VEGF189)36, 37. 
While in the first case due to loss of directionality during branching, resulting vessels were large in 
diameter and less branched in the latter case extensive filopodia formation, highly branched 
and thin vessels were observed.38 Similarly, the deletion of the C-terminal heparin binding motif 
of PDGF-BB resulted in abnormal coverage of pericytes, and their partial detachment from the 
vessel wall which for example manifests in defective vessels and consequently in retinal 
deterioration, or proteinuria.3, 39 These data indicate a role for the ECM immobilization of PDGF-
BB in the assembly of functional blood vessels. The C-terminal binding motif of PDGFs largely 
restricts its distribution and availability in vivo near to the site of productions, which in the case of 
vessels is in the perivascular zone.3 In the presented in vitro model, a synthetic protein linker was 
applied to mimic this natural PDGF-BB ECM interaction. Additionally, fabrication of a perfusable 
channel in the hydrogel allowed for controlling the PDGF-BB source and thereby creation of 
evolving as well as, in the case of matrix-interacting PDGF-BB, stable 3D PDGF-BB gradients. Stable 
PDGF-BB gradients restricted PDGF-BB-induced spreading and migration to the vicinity of the 
growth factor source. In contrast, the freely diffusible growth factor led to a transient gradient 
rapidly leveling out throughout the gel. Similar observations were made by Nguyen et al.,40 who 
recently described that a gradient formed in a hydrogel from a channel, initially spans over 300 
?m and covers over 900 ?m after 1h only. This short-term gradient of the growth factor lead to 
homogenous biological response throughout the entire model. These data indicate that the 
native perivascular organization of cells can be recapitulated in vitro by appropriate 
presentation of PDGF gradients. In 2D setups, soluble PDGF gradients were shown to induce 
fibroblast polarization and chemotaxis.41, 42 However, in the herein presented 3D setup, both 
soluble PDGF and the gradient of matrix-immobilized PDGF stimulated a chemokinesis related 
(stochastic) migration process. From these experiments it remains unclear whether during the 
formation of the gradient a short-term exposure of the MSCs to soluble PDGF, residual non-bound 
PDGF, or trace amounts of released PDGF were sufficient to induce non-directed migration or 
whether PDGF generally induces a migration process resembling chemokinesis. The high binding 
affinity of the ZZ-tag to Fc-domains (Kd = 4.8 * 10-8/M)43 would suggest, that the release of the 
growth factor would be mainly be due to the very slow (not yet carefully characterized) 
degradation of the PEG-based matrix by cell-mediated cleavage of built-in MMP-sensitive linker 
sequences14, 44. This indicates that although MSC migration might not occur in a highly directional 
fashion the sum of the PDGF-mediated processes leads to the assembly and stabilization of a 
perivascular niche. A further limitation of the current study is that in this simplified model the direct 
contact of MSCs with the vascular basement membrane, which is a known regulator of various 
stem cells, is not reproduced45, 46. Together, these observations indicate that our in vitro model 
recapitulates some of the dynamics that are assumed to be present during vessel formation, 
including the diffusion of trace amounts of PDGF from the site of production before the capturing 
by the glycosaminoglycan components of the ECM. Enzymatic remodeling of the ECM by 
mobilized cells is also represented by the slow MMP-dependent degradation of the PEG-matrix 
and the consequent release of PDGF. 
The steepness of the gradient and the protease-mediated release of PDGF from gradients can 
have a large influence on the amount of factor seen by a cell. As in this study these parameters 
were kept constant we cannot exclude that chemotactic migration would preferentially occur 
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in steeper gradients or upon cell-mediated promotion of release. Based on the observed slow 
degradability and thus the low availability for cells under evaluated cell culture conditions it is 
tempting to speculate that the graded PDGF reservoir is only very slowly exploited during the 
observed culture period. Both faster release kinetics and longer observations could thus clearly 
reinforce MSC function and even lead to improved tissue morphogenesis. 
This study was restricted to the description of the isolated mesenchymal compartment of the 
perivascular niche. Earlier in vitro studies have described models, which use both mesenchymal, 
and endothelial cells to create a perivascular niche47, 48. One approach which integrated 
microfluidic channels and 3D fibrin encapsulation of endothelial cells and MSCs revealed an 
important function of laminin to control the perivascular location of MSCs in an ?6?1 integrin 
mediated manner48. This finding correlates well with studies showing the perivascular location of 
neuronal stem cells46, 49 and the critical function of vascular basal membrane laminin to control 
MSC function by ?6?1 integrin and PDGF-BB signaling48, 50. The integration of endothelial cells with 
herein described perivascular niche model consisting of MSCs which are exposed to stable 
growth factor gradients might provide a promising platform for the studying of stem cells in their 
perivascular niche while varying individual cellular, matrix associated or soluble bio-molecular 
factors. 
 
CONCLUSION 
By combining advanced biomaterials with microfluidic technology we here present the creation 
of a spatially-defined tissue model recapitulating mechanical properties and stable PDGF 
gradients of the perivascular niche. We believe that this model and its further development by 
the incorporation of endothelial cells will help increase our understanding of the role of MSCs in 
vascular function as well as the cell extrinsic cues that control their fate. 
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4.1 _ ABSTRACT 
Synthetic hydrogels are excellent materials for the presentation and delivery of growth factors 
(GFs), which guide cell functions and promote tissue regeneration. Currently, novel GF-
functionalized hydrogels are used to test the effect of those GF on embedded microtissues and 
single dispersed cells. However, despite the extended use of these assays, they fail in isolating 
the effect of the bound and soluble factors due to the simultaneous gel formation, GF 
immobilization and cell embedding. Additionally, those assays are very limited in throughput, 
which restricts the number of simultaneous tests. Here, we use hydrogel casting methods to 
decouple gel formation, growth factor exposure and 3D cell encapsulation, which permits the 
GF loading before cell exposure and the testing of a large number of samples at the same time 
for an increased throughput. In this preliminary study, we first took advantage of hydrogels that 
were formed with surface gradients to show a correlation of cell invasion into the hydrogels with 
increasing amounts of soluble platelet-derived growth factor (PDGF). In a more complex wound 
model, we created a channel in a tissue mimic and filled it with a PDGF-loaded healing hydrogel. 
In this wound model, we observed the dramatic increase in cell recruitment into the PDGF-
releasing healing hydrogel. While this preliminary work did not include GF immobilization, it was 
an essential step for the establishment of healing models that can be used to determine the 
nature and optimize the concentration of biological cues towards wound healing. 
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4.2 _ INTRODUCTION 
Development of bioengineered materials in the tissue engineering and regenerative medicine 
field has been a topic of intense research interest in the past decades. Advances in materials 
science and biotechnology have led to the possibility to cultivate cells in hydrogels deprived 
from any biological signal.1,2 The properties of those biomaterials and their compatibility to a 
large amount of cell types make them particularly suitable for in vitro models. While 3D cell 
cultures have partially replaced conventional 2D assays, more work needs to be done to 
increase the architectural complexity of 3D cell culture models and to the further development 
of relevant models for the understanding of cell behaviour in vitro.  
In this study, we take advantage of the properties conferred by Poly(ethylene) glycol (PEG)-
hydrogels to reproduce a tissue defect and simulate its healing by the delivery of biological cues. 
To do so, we employed platelet-derived growth factor (PDGF), which is a strong activator of 
blood clot formation and wound healing process. This growth factor promotes proliferation, 
recruitment and stimulation of mesenchymal cells, which are essential in tissue repair.3-6 PDGF 
also plays an important role in the perivascular niche where it is secreted by endothelial cells, 
activates mesenchymal stem cells (MSCs) present in the surrounding, directs them towards the 
vasculature and by this contributes to the stabilization of blood vessels.7 
 
The ultimate goal of an in vitro model is its use to predict in vivo functional patterns of cells or 
tissues. In our vision of simulating wound healing, we aim to reproduce both the wounded tissue 
and the material delivering the healing triggering biological cues. For in vivo applications, the 
binding of GF to healing materials may be of relevance as it prevents its washing out, limits its 
effects to the site of application, and facilitates the minimization of its concentration for efficient 
cell stimulation.8-11 Current techniques like hydrogel encapsulation of microtissues or 
homogeneous 3D cell cultures have an important drawback when it comes to testing the effect 
of bound factors. Indeed, to discard the soluble fraction of the signals, GF attachment should 
be followed by extensive washing steps before cell encapsulation. This is not possible in these 
methods where cells are encapsulated before or simultaneously to GF attachment. Other studies 
show invasion of cells in gels casted prior to cell seeding. However, they use native-derived 
materials like hyaluronic acid12 or collagen,13 which might have inherent bioactive effects on the 
cells. 
In this work, we use a gel formation method that confers physical properties enabling cells to be 
seeded in 3D even after hydrogel polymerization.14,15 This characteristic has the advantage of 
decoupling gel fabrication, GF binding and cell exposure, making it a perfect tool for evaluating 
the effect of bound GF only. However, before investigating the effect of GF attachment, it is 
important to validate this cell culture platform as a quantification method for cell activity. A 
previous study showed the use of this gel formation technique for cultivating multiple cell types 
and the sequential seeding of cell populations.16 This is realized by the local inhibition of PEG 
polymerization at the surface of the gel, making the gel surface very soft, which enables cells to 
infiltrate the gel even after the gel polymerized. 
Wound healing model 
66 
 
Here we highlight the potential to use this platform as a tool to measure growth factor activity 
by quantifying cell invasion into the gels at different soluble GF concentrations. We took 
advantage of the rapid simultaneous fabrication of 96 gels and developed and optimized scripts 
to automatize image acquisition and data processing to minimize the time of experiments. 
Finally, based on the same technology of polymerization inhibition, we developed a platform 
enabling the reproducible formation of channels in PEG hydrogels as a wound model. This 
channel, mimicking a wound, was then filled with another hydrogel carrying biological cues 
promoting wound healing. We then assessed the rate of cell recruitment and colonization inside 
the loaded healing gel, which can be used to quantify the capacity of bioactive candidates for 
promoting wound healing. 
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4.3 _ MATERIALS AND METHODS 
CELL CULTURE 
Bone marrow aspirates were obtained from healthy donors (average age 28 y.o.) after informed 
consent during orthopaedic surgical procedures in accordance with the local ethical 
committee (University Hospital Basel; Prof. Dr. Kummer; approval data 26/03/2007 Ref Number 
78/07). Cells were isolated as described previously.17,18 Human bone marrow MSCs were cultured 
in minimal essential medium alpha (MEMalpha, Gibco Life Technologies, cat. no. 22571-020) 
supplemented with 10% (v/v) fetal calf serum (FCS, Gibco Life Technologies, cat. no. 10500), 1% 
(v/v) penicillin/streptomycin solution (Gibco Life Technologies, cat. no. 15140-122) and 5 ng ml-1 
FGF-2 (Peprotech, cat. no. 100-18B). For experiments, MSCs were cultured in the same medium 
without FGF-2. MSCs between passages 1 and 3 were used for all of the experiments. 
 
PREPARATION OF PEG HYDROGEL-GRADIENT 96-WELL PLATES 
Matrix metalloproteinase (MMP)-sensitive TG-PEG hydrogels functionalized with RGD were 
prepared based on previously described transglutaminase cross-linked PEG hydrogels.17,18 In 
brief, eight-arm PEG precursors containing the pending factor XIIIa substrate peptides glutamine 
acceptor (n-PEG-Gln) or lysine donor with an additional MMP-sensitive linker (n-PEG-MMPsensitive-
Lys) were mixed stoichiometrically (final dry mass content 1.5%) in Tris-Buffer (50 mM Tris, pH 7.6) 
containing 50 mM calcium chloride. 50 ?M Gln-RGD peptide were added to the precursor 
solution prior to initiation of cross-linking by 10 U ml-1 thrombin-activated factor XIIIa and vigorous 
mixing. 
20ul of the precursor solution was added in each of the 96-wells and electrochemical process 
was applied on top of the gels to inhibit the polymerization at the surface of the gel. This resulted 
in the simultaneous production of 96 hydrogels with cross-linking gradient. This characteristic 
property, more precisely described in a previous study16, makes the gels adequate for cultivating 
cells in 3D after gel formation. 
 
CELL INVASION IN HYDROGEL GRADIENT 
In every well, 15’000 MSCs were seeded on the hydrogel gradients in 50ul minimal essential 
medium alpha supplemented with 10% FCS and 1% penicillin/streptomycin and left to adhere to 
the gel surface for 30 minutes. 50ul of the same medium, complemented with growth factor (GF), 
was added to each well. The samples were fixed with 4% paraformaldehyde after 3 days of 
culture. The reaction was stopped with 0.1M glycine in phosphate-buffered saline (PBS) and the 
samples were washed 3 times for 5 minutes with PBS. The cells were permeabilized with 0.2% 
TritonX 100 in PBS for 30 minutes followed by 3 times of 5 minute washing steps with PBS. 
Rhodamin-phalloidin (1:300, Invitrogen, Carlsbad, CA, USA) and 4',6-diamidino-2-phenylindole 
(DAPI, 1ng/ml, Sigma Aldrich, St Louis, MO, USA) in PBS were added overnight at 4°C and rinsed 
3 times for 15 minutes in PBS. 
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Cell imaging was done using an inverted confocal microscope (Leica TCS SP5) to acquire 500?m 
stacks. Images were taken at 10x magnification with a 6?m step size. Cell nuclei and actin 
cytoskeleton signals were acquired in an automated manner for the whole plate.  
Imaris® 7.7.2 (Bitplante AG, Zurich, Switzerland) was used for image processing. DAPI signal were 
were reconstructed using the dots surpassing tool (XYZ diameter estimates = 15, 15, 25?m; Quality 
above 5). Statistics of those dots (XYZ position) were exported as .xls file into a self-developed 
MATLAB script for data analysis. 
 
PREPARATION OF THE PDMS FRAMES 
Polydimethylsiloxane (PDMS) frames were made as described previously.15 In short, the silicon 
elastomer and the curing agent (Sylgard 184, Dow Corning Corporation, USA) were mixed (10:1 
in mass) at 2000 rpm for 3 minutes in a ARE-250 mixer (Thinky Corporation, Japan). The mixture 
was subsequently poured into poly(methyl methacrylate) (PMMA) molds, where 500 ?m in 
diameter stainless steel wires were positioned to create the holes for the future electrodes. The 
mixture was subsequently degassed for 30 minutes in a vacuum chamber and baked for 4 h at 
60°C. The stainless steel wires and the PDMS forms were removed from the PMMA molds, rinsed 
with isopropanol (IPA), oxygen plasma cleaned (1min at 300 W, Plasma-System 100, Technics 
Plasma GmbH, Germany) and finally, pressed onto plasma cleaned microscope glass cover 
slips. 
 
CELL INVASION INTO WOUND HEALING MODEL 
Perfusable channels with a diameter of 500?m were produced in TG-PEG hydrogels (1.7% dry 
mass) as described previously.15 Briefly, straightened Tungsten wires (W, 500 ?m in diameter, 
Advent Research Materials Ltd, UK) were inserted in the PDMS forms and connected to a 
potentio-galvanostat in a two electrode setup (PGU-10V-1A-IMP-S and ECMwin computer 
interface, Elektroniklabor Peter Schrems, Germany). 60?l of complete TG-PEG hydrogel mixture 
containing MSCs were poured before the onset of gelation into the PDMS frame (Figure 4.3A). 
The polymerization of the TG-PEG was allowed to progress for 10 minutes while the Tungsten wire 
was anodically polarized (2 V DC, versus a Platinum auxiliary electrode). The gels were covered 
with 100 ?l cell culture media (MEM alpha, 10% FCS, 1% P/S) and left in the incubator at 37°C 
overnight. 8?l of TG-PEG gel precursor solution containing 20?M of TG-DyLight™550 with or 
without GF, called here the “healing hydrogel”, was added in the PDMS injection chamber. After 
1 minute of polymerization, the Tungsten wires were removed, leading to the suction of the 
healing hydrogel into the channel. Another wire was inserted in the opposite side of the channel 
to seal the system. Cell culture media (100ul MEM alpha, 10% FCS, 1% P/S) was added only 10 
minutes later to enable polymerization of the healing hydrogel in the channel. The samples were 
incubated for 3 days at 37°C and 5% CO2 in a humidified atmosphere. 
Cells were fixed and stained as described in the previous paragraph. Confocal microscopy was 
used to image 500?m gel stacks. DAPI and actin filaments were imaged to visualize the cells and 
DyLight550™ to localize the channel. Imaris® was used for reconstruction and image processing. 
The healing hydrogel was reconstructed using the surface surpassing tool on the DyLight550 
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signal (Surface Grain Size = 10?m; Diameter of Largest Sphere = 22.7?m; Manual Treshold Value 
= 21.7853?m; Manual Treshold Value B = 58.85?m; “Number of Voxels” above 8.56e5) and DAPI 
signal was surpassed with the dots reconstruction tool similarly as described in the previous 
paragraph. DAPI signal outside of the channel reconstruction was set to zero to keep only the 
nuclei inside of the healing hydrogel. The recruitment index was defined as the concentration of 
dots inside this healing material. 
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4.4 _ RESULTS 
 
4.4.1 _ HYDROGEL GRADIENTS FOR CELL ACTIVATION ASSESSMENT 
The invasion of stem/progenitor cells into the wound is a critical step in the healing process.19 
Thus, healing materials injected into wounds need to have the capacity to promote cell 
migration. Gradient hydrogels were used to establish a model to quantify cell invasion (Figure 
4.1). Thanks to the simultaneous fabrication of these PEG hydrogels in a 96-well format, different 
PDGF concentrations could be tested at the same time under very reproducible conditions in a 
significant number of replicates. After 3 days of culture time, image acquisition, processing and 
data analysis were all implemented in a self-made program to automate the process and 
minimize time. 
 
INVASION INDEX AS A PARAMETER FOR MSCS RESPONSE TO GF 
First of all, we focused on the establishment of an algorithm counting the spots dispersed in the 
hydrogel and measured the invasion index by calculating the ratio of non-invading cells to 
invading cells. To discriminate between non-invading and invading cells, we defined cells 
present within 50?m of the surface of the gel as non-invading and the ones beneath as invading 
(Figure 4.1). However, due to irregularities caused during the fabrication of the 96-well plate, the 
hydrogels did not present a perfectly flat surface, making it impossible to define the surface 
coordinates. In order to tackle this problem, we subdivided each stack into 16 x 16 (=256) sub-
stacks in the surface plane (Figure 4.1B). In each stack, we defined the coordinate of the sub-
surface as being the average position of the first cell starting from the top of the gel. The invasion 
indexes were calculated for each sub-stack and added up to get the invasion index of the 
whole sample. We compared this method to a method without subdivision. In this case, 256 
(16x16) times more cells were taken to define the surface of the whole sample. In addition, to 
assess the influence of the cells needed to define the surface coordinates, 4 times more cells 
were chosen for each method. The data in Figure 4.1C shows that the invasion indexes vary 
considerably depending on the method used. Without subdividing the sample, 79% and 64% 
were considered to be invading the hydrogel, while this index dropped to 43% and 41% when 
subdividing the sample. Interestingly, the number of cells taken to define the surface had a 
bigger impact when considering the whole sample. In this case, increasing 4 times the number 
of cells made the invasion index drop by 15% while this drop was only 2% in the subdivision 
method. Hence, the subdivision method, which is a more representative method of the local 
topographic variations of the gel surface, proved to bring a significant improvement in the 
measurements of cell invasion. It was thus validated as the method of choice for the assessment 
of the level of invasion on hydrogel gradients in vitro. 
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Figure 4.1. Schematic representation of the cell invasion assay on gel gradient. 96 gel gradients are formed 
simultaneously by electrochemistry mediated inhibition of polymerization. Cells are seeded on the gels and 
media with or without treatment is added to the wells. Images are acquired and numerical reconstruction is 
made to measure the position of cell nuclei. Data is analyzed and invasion index calculated following 
threshold parameters defining if cells are considered non-invading (within 50µm of the surface) or invading 
(below 50µm). 
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GF CONCENTRATION DEPENDENCE OF BM-MSCS INVASION INDEX  
Next, we used this platform and the algorithm to quantify invasion dependency to GF 
concentration. Human BM-MSCs (15’000 cells) were seeded on each hydrogel and PDGF was 
added in the culture media. After 3 days in culture, in the absence of GF, only 8% of the cells 
invaded the gel (Figure 4.2). In opposition, the results showed a significant increase in cell 
invasion into the gels with higher PDGF concentrations. The invasion index raised to 20%, 29% and 
32 % for 25, 50 and 100ng/ml PDGF respectively. Thanks to the hydrogel formation method and 
the image acquisition and data analysis, we could generate those results in a very limited 
amount of time for an important number of samples simultaneously. In addition, the GF 
concentration dependency of invasion index supported the potential of this method to measure 
activation potential of GF.  
 
 
 
Figure 4.2. Invasion of BM-MSCs in hydrogel gradients depending on PDGF concentration. Images of the 
numerical reconstructions of DAPI signal by the dots surpassing tool in Imaris® depending on soluble PDGF 
concentration present in the medium. The white boxes represent the image stack acquired and the dense 
cell line is the surface of each gel gradient. Cells migrated downwards into the gel mass. The histogram shows 
the quantification of the invasion index for each group (n=5, **:p<0.02). 
 
 
4.4.2_ HYDROGEL WOUND MODEL TO QUANTIFY HEALING POTENTIAL OF GFS 
 
ESTABLISHMENT OF A WOUND MODEL IN PEG 
While the method above was established to assess the activation potential of bioactive cues on 
a large number of samples in parallel, a more complex model composed of a wound mimic in 
a tissue model shall provide a more realistic tool to evaluate the healing potential of materials. 
Our approach consists cultivating cells in a hydrogel to mimic a tissue and creating a channel 
inside of this gel to simulate a wound, in which another hydrogel is injected as healing promoter. 
The way this was done is shown in Figure 4.3C-F where the steps of the procedures are 
schematized sequentially. First, electrochemistry is applied on a conductive rod during the 
polymerization of the tissue mimic. This method enables the reproducible formation of channels 
in hydrogels.15 The healing hydrogel (Figure 4.3C-F, red) is then placed in an injection chamber 
and sucked into the channel by pulling out the rod once the first signs of polymerization appear. 
Another rod was then added in the opposite side of the channel to confine the healing gel. 
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Injection of synthetic hydrogel into a pre-cultivated, cell-containing synthetic hydrogel 
depended on the reliable formation of the channel and the proper timing of gel perfusion and 
polymerization. To do so, the design and geometry of the mold showed in Figure 4.3A was 
carefully defined and optimized. PDMS was chosen as a support for the model because of its 
inert biological properties and its facile production into desired shapes. First, it contains a bottom 
well (Figure 4.3B, Gel-filled well) were the hydrogel tissue mimic is casted. This bottom well was 
designed with a small edge to prevent hydrogel adherence to the mold’s walls and consequent 
meniscus formation and gel deformation. A second, wider well was formed on top to limit media 
volume to a maximum of 250?l (Figure 4.3B, Culture media well). Next, an injection chamber was 
added to the mold as inlet for the healing material (Figure 4.3B, Injection chamber). The design 
of this chamber contributed to the efficiency of the wound model. Indeed, the column pressure 
generated by the height of it contributed to the efficient suction of the healing gel into the 
wound mimic. The reduction of this height resulted in poor reproducibility of suction (data not 
shown). The injection chamber inlet was also deliberately high to keep the inlet away from the 
cell culture media, preventing any media residues to be mixed with the healing hydrogel 
precursor. Finally, the PDMS mold was mounted on a cover slip glass to enable imaging of the 
hydrogels. Figure 4.3B shows a cross-section of a confocal image resulting from the injection of 
a healing hydrogel (red) into an empty, previously formed gel (white). The image was acquired 
3 days after its formation proving that the injected hydrogel polymerized and was stable inside 
the pre-cultivated gel. This was only reliably done thank to the higher column of the injection 
chamber and when suction was done once the healing hydrogel started polymerizing. Early 
suction resulted in diffusion of the gel precursors and bad polymerization (data not shown). 
 
 
 
Figure 4.3. Wound healing model. A) Photo of the PDMS mold. B) Orthogonal cuts of a stack imaging acquired 
by confocal microscopy. In white the bulk hydrogel and in red the healing hydrogel in the channel. The 
fluorescent tags were covalently bound to both hydrogels during polymerization. (scale bar: 250?m). C) 
Schematic representation of the PDMS mold. D)-G) The tissue mimic (blue) is casted into the PDMS frame 
(black) while a current is applied on the tungsten wire (black line) during polymerization. The healing gel (red) 
is loaded in the loading well and polymerizes for 1 minute. Another wire is added at the open side to close 
the opposite access site. The tungsten wire is pushed back to suck the healing gel in and fill in the channel 
(i.e. wound). The opposite wire is pushed in towards the channel to seal it. (mold width = 1.5cm) 
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CELL RECRUITMENT POTENTIAL OF PEG HYDROGELS DELIVERING PDGF IN A WOUND MODEL 
The injected gel enables the cells to be recruited from the surrounding tissue mimic into the 
healing hydrogel and imaging methods can then be used to quantify the level of cell 
recruitment. This way, one can test the potential of biological signals to promote tissue 
regeneration and find best candidates for wound healing. Here we inject healing hydrogels 
containing no or 1ng/?l PDGF in a pre-cultivated tissue mimic containing 2x106 cells/ml. After 3 
days of culture, we compared the concentration of cells present in the healing hydrogels 
depending on whether or not PDGF was delivered by that healing material. To do so, we used 
the “surpassing” method in Imaris® to reconstruct DAPI signals into spots and reconstructed the 
DyLight™550 signal into the healing hydrogel. We measured the recruitment concentration by 
counting the dots present within the reconstructed healing hydrogel and dividing by its volume. 
Figure 4.4A-D shows the images of the sample where no GF was delivered and Figure 4.4E-H 
when PDGF was delivered by the healing hydrogel. Figure 4.4A and E shows the raw image stack 
in a 3D projection with, in red, the DyLight™550 signal bound to the healing hydrogel and in 
yellow the DAPI signal from the cell nuclei. Figure 4.4B-D and 4.4F-H show the reconstructed 
images after exclusion of the DAPI signal not present within the healing hydrogel. The histogram 
in Figure 4.4 shows a significant increase in cell concentration in the presence of PDGF. The 
concentration was 714 ± 215 cells/mm3 when PDGF was present and 193 ± 164 cells/mm3 when 
an empty gel was injected. By confirming the differential activation patterns with or without 
PDGF, these observations attest of the feasibility and utility of our wound model as a 
quantification method for the recruitment potential of growth factors. 
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Figure 4.4. Cell recruitment into a healing hydrogel containing PDGF. A) and E) show a 500µm thick confocal 
imaging stack with the raw signals of DAPI (yellow) for cell nuclei and DyLight™550 (red) for the healing 
hydrogel. B) and F) are the numerical reconstruction using surface surpassing for the DyLight™550 signal and 
spots surpassing for the DAPI. Only the DAPI signal co-localizing with the DyLight™550 reconstruction was 
surpassed by spots. C) and G) represent the side view of this reconstruction. D) and H) are the front view of 
those stacks. A) to D) are the images of a representative sample where no GF was added, while E) to H) had 
1ng/?l GF loaded in the healing material. The histogram shows the cell concentration in the healing hydrogel 
when loaded with or without GF. (n = 6 for the GF group and n = 4 for the noGF group), mold size is 1.5x1.5mm, 
**:p<0.02). 
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4.5 _ DISCUSSION 
In this study, we established two different models that succeeded in showing their efficiency in 
quantifying the influence of GF treatment on cell activation. PDGF concentration dependency 
of BM-MSC activity was used to validate our platforms by corroborating our results with the 
existing observations.4 There is no doubt about the relevance of using such platforms in tissue 
engineering and regenerative medicine. In a wound-healing context, the evaluation of the 
influence of biological cues on cell behaviour is of prime interest. 
 
HYDROGEL GRADIENTS FOR CELL ACTIVATION ASSESSMENT 
Measuring the invasion index provides to the experimenter a direct read-out on how those 
biological cues can affect cell migration. The data showed the potential of the gel gradient well 
plates to reliably quantify GF influence by correlating GF concentration and invasion index. In 
addition, the automation of manufacturing, image acquisition and data processing provided 
the ability to run a large number of samples in a limited amount of time. Indeed, 96-well gel 
formations were completed in 10 minutes, image acquisition ran automatically for 1 hour and 
data analysis occurred in a couple of seconds. This automation is extremely valuable when 
testing multiple bioactive cues in a statistically relevant number of replicates for a screening 
assay. We also showed that the data gained value by the use of our subdivision method. Indeed, 
without this correction, the invasion index was greatly influenced by the number of cells taken 
to define the overall surface and did not consider possible variation in surface topography or 
overall surface tilt. In this case, some cells underneath the overall surface threshold were 
considered as invading even though they were on the gel surface, leading to significantly higher 
invasion index without the subdivision method. Redefining smaller stacks helped correcting local 
irregularities and showed more representative results.  
 
A significant advantage of the gel gradients resides in their characteristic uncoupling of gel 
formation and cell seeding. This unique feature permits the production of gels prior to cell 
seeding without losing the 3D cell culture property. The most logical future experimental assay 
would be the assessment of the influence of GF binding to the hydrogel backbone. Indeed, it is 
known that GF activity varies if bound to the hydrogel. The method presented could allow gel 
formation with covalently and/or affinity bound GF to the backbone followed by washing and 
cell exposure to GF. In this set-up, all non-bound GF would be discarded and the resulting cell 
migration would only be the consequence of the bound portion. This could be of major interest 
for the design of materials aiming to deliver bioactive cues at wounded sites, define their range 
of working concentrations and possibly tune and/or combine GF releasing kinetics for optimal 
cell response. 
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HYDROGEL WOUND MODEL TO QUANTIFY HEALING POTENTIAL OF GFS 
A further step in this work consisted in combining the findings of the migration triggered by the 
GF treatment with a model of wound. A pre-cultivated hydrogel containing a homogeneous 
population of MSCs was taken as a tissue model in which a channel was formed to mimic a 
wound. Electrochemistry showed to be an efficient and reliable method to form those channels 
and enabled the suction of another PEG gel aiming to heal the wound mimic by delivering GF. 
The data showed that this PEG-PEG hybrid model can be a representative model for mimicking 
tissues, their wound and the delivery of a potential healing material. The presence of cells in the 
healing material attests that the cells constituting the tissue model were actively recruited by the 
inserted hydrogel. This data corroborated with the gel gradient model where cells invaded the 
gel only in the presence of GF.  
This model makes possible more extensive investigation of the effect multiple GFs delivery. The 
combination of multiple GFs can be of relevance to mimic biological process where GF are not 
exposed alone, as for example shown in previous studies about blood vessel homeostasis.20,21 In 
addition, the biochemical properties of PEG hydrogels enable the binding of biological cues 
and the engineering of cleavage sites with different kinetic properties. This can be used as a tool 
to attach different GF with different binding affinities to different cleavage sites, making possible 
a time-dependent GF release. This could be integrated in the wound healing model presented 
here to assess the effect of sequential GF exposure and bring one relevant method for the fast 
developing trend of 4D biomaterial engineering.22 
 
CONCLUSION 
This work succeeded in showing the potential use of the gel gradient platform for in vitro 
evaluation of the influence of biological cues in 3D. The possibility to run a large number of 
experiments in parallel pushes further the barrier of experimental design. Multiplexing, combining 
and repeating is now made easier even in 3D, with the advantage of being able to dissociate 
gel formation and cell exposure. In addition, we developed a wound model and showed the 
relevance of its method to simulate the delivery of biological cues at a wounded site. Both 
models are complementary to each other and we firmly believe that they carry serious potential 
for tissue engineering, regenerative medicine as well as drug screening purposes in 3D and, in 
the near future, in 4D. 
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5.1 _ ABSTRACT 
Synthetic hydrogels have been extensively used to recreate cellular microenvironments and to 
engineer tissues, yet the contribution of the cell-secreted extracellular matrix in these applications 
is insufficiently investigated. Cells grown in those hydrogels deposit their own extracellular matrix 
(ECM), providing a structural and functional environment of specific composition. Dissection of 
the exact composition of those engineered tissue mimics can be of importance to verify the 
fidelity of those in vitro models depending on the treatment provided to the cells. Here we chose 
a tandem mass spectrometry method (LC-MS/MS) to analyze the matrix deposited by bone 
marrow mesenchymal stem cells (BM-MSCs) embedded in 3D poly-ethylene glycol (PEG) 
hydrogel. We used a label free quantification method to determine the matrix composition 
following treatment with different growth factors (GFs). This study proved that LS-MS/MS is an 
efficient method to selectively identify the proteins deposited in 3D synthetic hydrogels. Results 
indicate a direct influence of GF treatment on matrix protein deposition. The protein abundancy 
also varied significantly depending on the sequence in which the GFs were administered, raising 
the importance of GF choice and sequence to obtain the protein composition wanted, which is 
most crucial in tissue engineering applications. 
 
  
Proteomics 
81 
 
5.2 _ INTRODUCTION 
The extracellular matrix (ECM) is a complex network of proteins forming the environment in which 
the cells reside. Cells use their transmembrane proteins to adhere to this ECM, which gives them 
a 3D architectural support.1-5 The attachment of the cells to ECM proteins triggers signaling 
pathways that are at least as important as soluble cues in influencing cell behavior and biological 
processes.6 Indeed, these proteins play an important role in cell survival, proliferation, migration 
and fate.7-13 In addition, ECM proteins can bind a number of growth factors, thereby inhibiting or 
increasing their activity.14-18 Deregulation in this tight controlled dynamic between ECM and cells 
has been directly linked to pathologies like marfan syndrome or cancer, which highlights the 
importance of a specific ECM protein composition for cell regulation and organ function.6,19-21 
Previous studies have focused on identifying the proteins forming the ECM, also called matrisome, 
and classified them into two categories, the core matrisome and the matrisome associated 
proteins.22,23 The core matrisome constitutes the architectural blocks of the ECM and is split into 
three categories: the collagens, the glycoproteins and the proteoglycans. The collagens are 
mainly responsible for the tensile strength and the elasticity of the tissue.3,24-26 The glycoproteins 
play an important role in cell adhesion, signaling and GF binding. And the proteoglycans, which 
are glycoproteins with attached glycosaminoglycans (GAGs), help retain water in the tissue and 
are also known to bind growth factors.6 
 
One of the goal of tissue engineering is to create 3D tissue replicates to study cell response to 
biological cues and to develop novel treatment approaches under controlled in vitro 
conditions.27,28 Since ECM composition has a direct influence on cell functions, gaining 
knowledge about the exact composition of the ECM produced by cells in 3D can be crucial for 
the relevance of the in vitro model. Poly-ethylenge glycol (PEG) hydrogels are an example of 
synthetic materials developed for 3D cell culture. They have been designed to enable the 
experimenter to tune the cellular environment to direct cell behavior. For example, small peptides 
like the cell adhesion motif RGD or matrix metalloproteinase (MMP)-sensitive sites can be added 
to provide an ECM-like support and enable cell survival, spreading and migration without 
triggering any cell response.29-31 One of the main advantages of PEG over other hydrogels used 
for 3D cell culture like Matrigel™ or collagen is its blank and biologically inert backbone. This 
makes PEG particularly adapted for the identification of ECM proteins in response to biological 
cues. Indeed, because of the absence of proteins in PEG hydrogels, the presence of proteins in 
the hydrogel can be attributed to the sole cell origin and allows to assign protein variation to the 
specific biological stimuli added to the cell cultures.12,30,32 Natural substrates like Matrigel™ or 
collagens are protein-based materials, thus, the presence of protein signals originating from the 
cells cannot be distinguished from the protein signals originating from the hydrogel itself. 
More than just in vitro platforms, hydrogels have recently been used as cell carriers for the 
initiation of tissue repair in vivo. One of the reason for the low success rate of those cellular 
therapies is caused by the low cell survival rate in the hydrogel implants.33 This can be partly 
explained by the inappropriate composition of the carrier matrix. Precise definition and 
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reconstruction of the native cell microenvironment before implantation could thus provide those 
implants with a significant advantage and improve the success rate of cell therapy.  
 
Currently, the identification of the proteins composing the cell´s own ECM relies mainly on 
immunohistochemistry and next-generation RNA sequencing for transcriptome analysis.34 The first 
method has the advantage of enabling visualization of intact structures in the spatial 
configuration of the tissue in a sensitive manner. However, it requires the targeting of specific 
proteins whose antibodies are available, which is an important limitation to the identification of 
an unknown set of proteins. In addition, fluorescent imaging is not adapted for multiplexing due 
to the limited number of color channels and imaging of 3D hydrogels does not allow reliable 
quantification of protein level variations. In opposite, transcriptome analysis has a greater 
sensitivity due to its amplification steps that increases signal intensity. However, the detection and 
quantification focuses on the messenger RNA and does not take into consideration the 
translation efficiency and post-transcriptional protein stability. Hence, it does not necessarily 
represent the real amount of proteins produced and deposited.35 
 
In recent 2D in vitro studies, tandem mass-spectrometry and label free quantification proteomics 
have been used to analyze the ECM produced by stem cells in a multitude of different culture 
conditions.36-40 More commonly, proteomics has also been used on native or decellularized 
organs to characterize the ECM composition and understand tissue organization and 
physiology.41-48 In such studies, comparison of healthy control to “diseased” samples (e.g. aging, 
cancer) allow the identification of different ECM composition. This knowledge can then be used 
to identify new drug targets and/or therapies.37,38,49-53 While those experiments on native tissues 
have made the best use of proteomics tools, there is a lack of studies identifying and quantifying 
the ECM proteins present in synthetic hydrogels. 
In this study, we present a label-free quantification proteomic approach to identify and quantify 
the ECM composition on a direct protein level. Opposed to recent work where only the culture 
medium was analyzed,54,55 we studied the ECM proteins produced and deposited by bone 
marrow mesenchymal stem cell (BM-MSC) inside the PEG hydrogels. We tested various culture 
conditions with different GF stimuli at different time points. One stimulus was transforming growth 
factor beta1 (TGF?1), which is responsible for the stimulation of BM-MSCs differentiation into 
chondrocytes, for the inhibition of adipogenic differentiation and for modulating tissue 
remodeling during repair processes.56,57 Additionally, TGF?1 has been reported to have a 
stimulating effect in ECM protein deposition in particular collagen and fibronectin.58-60 The other 
GF stimulus was the combination of platelet-derived growth factor (PDGF) and epidermal growth 
factor (EGF). Those GFs are strong metabolic activators and trigger migration and 
proliferation.56,60-63  
By deciphering the matrisome components, we could identify the building blocks of the 
environment created by the cells on a plain canvas and illustrate a way to influence their 
composition. This information is of crucial use in tissue engineering and regenerative medicine, 
where the fidelity of the in vitro models to the native tissue is determinant for the quality of the 
investigations. 
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5.3 _ MATERIALS AND METHODS 
CELL CULTURE 
Human BM-MSCs were obtained from healthy donors during orthopedic surgical procedures after 
informed consent and in accordance with the local ethical committee (University Hospital Basel; 
Prof. Dr. Kummer; approval data 26/03/2007 Ref Number 78/07). The cells were cultured in 
minimal essential medium ? (MEM?, Gibco Life Technologies, cat. no. 22571-020) with 10% (v/v) 
fetal bovine serum supplement (FBS, Gibco Life Technologies, cat. no. 10500), 1% (v/v) 
penicillin/streptomycin (Gibco Life Technologies, cat. no. 15140-122) and 5 ng ml-1 FGF-2 
(Peprotech, cat. no. 100-18B). BM-MSCs at passage 2 were used for all experiments at a maximum 
confluence of 90%. 
 
SINGLE CELLS ENCAPSULATION IN TG-PEG HYDROGELS 
We prepared TG-PEG hydrogels as described previously.29,31 In brief, the two eight-arm PEG 
macromers (n-PEG-Gln and n-PEG-MMPsensitive-Lys) were mixed stoichiometrically for a final dry 
mass of 1.7% in Tris buffer (50mM, pH7.6 with 50mM calcium chloride). The adhesion peptide Gln-
RGD (50?M) was added to the solution. BM-MSCs in MEM?, 10% FBS and 1% 
penicillin/streptomycin were added for a final concentration of 1.5 Mio cells per milliliter of 
hydrogel. Factor XIIIa (10U ml-1) was then added to initiate PEG polymerization. Drops of 16?l of 
the gel preparation were then deposited in 96 well plates and the plates were rotated every 30 
seconds during 4 minutes to prevent sedimentation of cells during hydrogel polymerization. After 
15 minutes, 200?l of MEM?, 1% penicillin/streptomycin without FBS was added and the plates 
placed in the incubator (37°C, 5% CO2) for 30 minutes. This media was then replaced by media 
supplemented with growth factors according to different treatment groups. 
 
GROWTH FACTOR TREATMENT 
We added 100?l of media with the selected GFs in each well. Negative control consisted of basal 
medium for all the groups (MEM?, 1% penicillin/streptomycin without FBS). Ascorbic acid (50 
?g/ml) was added to all the treatment groups. Total treatment time was 20 days with medium 
renewal every 5 days. The treatments were composed of different GF stimuli. One stimulus was 
transforming growth factor beta1 (TGF?1, 100?g/ml) and the other was the combination of 
platelet-derived growth factor (PDGF, 100?g/ml) and epidermal growth factor (EGF, 100?g/ml). 
At the end of the treatment time, 200?l basal medium was added for 30 minutes to wash the gel 
of its soluble components. 
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ECM RETRIEVAL 
The basal medium used for washing was discarded and 45?l of 0.05% Trypsin-EDTA (Gibco Life 
Technologies, cat. no. 25300-062) was added to digest the hydrogel. We pooled together 3 wells 
and retrieved 170?l in separate 500?l Eppendorf vials. They were then centrifuged for 10 minutes 
at 5000 x g to separate the cells from the hydrogel digestion. 150?l of the supernatant was taken, 
to which 45?l Trypsin was added overnight at room temperature to further digest the ECM protein 
into peptides. 
 
CYTOSOLIC PROTEINS RETRIEVAL 
SDS lysis buffer (4%(w/v) SDS, 100 mM Tris/HCL pH 8.2, 0.1M DTT) was added to the cell pellets in a 
1:10 sample to buffer ratio and sonicated for 10 min. Samples were boiled for 5min at 95°C 
followed by 10min sonification. 30?l of sample was mixed with 200?l of urea buffer (8M urea in 
100mM Tris/HCl pH 8.2) and the loaded on to Microcon – 30 filters (Merck Millipore Ltd, cat. No. 
MRCF0R30) by centrifugation at 14’000 x g. All following centrifugation steps were performed at 
14’000 x g. Samples were washed with 200?l of urea buffer and wash solution was removed by 
centrifugation. Modification of Cys residues was performed by adding 100?l of 0.05M 
iodoacetamide in urea buffer on the filter, incubation for 1min at 600rpm and 5min w/o mixing 
at room temperature. Reaction solution was removed by centrifugation and samples were 
washed three times with 100?l of urea buffer and two times with 0.5M NaCl solution. The flow 
through of all steps was discarded. Filters were transferred to fresh collection tubes and 120?l of 
0.05 Triethylammoniumbicarbonat containing 4ng/?l sequencing grade trypsin (Promega, cat. 
No. V511A) was added. Digestion was performed over night at room temperature in a wet 
chamber. The reaction was stopped by adding 5% TFA to a final concentration of 0.5% TFA. 
Peptides where harvested by centrifugation and desalted prior to mass spectrometry analysis. 
 
 
ECM PEPTIDE COLLECTION AND SAMPLE PREPARATION 
ECM samples were acidified by adding 5% trifuloroacetic acid (TFA) solution to a final 
concentration of 0.5% TFA in the sample. 25?l of 3% acetonitrile (ACN), 0.1% TFA was added to 
each sample prior to desalting on self-packed C18 stage tips. All following steps were performed 
at 2000 x g. Stage tips were cleaned 1x with 150?l 100% methanol and 1x 150?l 60% ACN/0.1%TFA 
by centrifugation for 1min. The stage tips were equilibrated with 2x 150?l of 3%/0.1%TFA by 
centrifugation for 1min. The samples were loaded in the stage tips by centrifugation for 10min 
followed by washing 2x with 150?l of 3% ACN/0.1%TFA. Peptide where eluted and collected into 
a fresh tube with 150?l of 60% ACN/0.1% TFA and centrifugation until complete stage tip dryness. 
The samples were dried to completeness by vacuum centrifugation and re-suspended in 16?l 3% 
ACN/0.1% formic acid (FA). Prior to mass spectrometry analysis this sample solution was further 
diluted 20x in 3% ACN/0.1% FA. 
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ANALYSIS BY MASS SPECTROMETRY (LC-MS/MS) 
For each sample we analyzed 4?l  on a LTQ-Orbitrap Fusion mass spectrometer (Thermo Scientific) 
coupled to an nanoEasy LC 100 (Thermo Scientific). Full scan MS spectra were acquired from 300-
1500 m/z with an automatic gain control target of 4e5, an Orbitrap resolution of 120’000 (at 200 
m/z) and a maximum injection time of 50 ms. Internal mass calibration was performed using the 
two lock mass 371.101 m/z and 445.1200 m/z. Precursor for ms2 scans where isolated with the 
quadrupole with a window of 1.6 Da, an automated gain control value of 2000 and a maximum 
injection time of 300 ms. HCD fragments were generated using a normalized collision energy of 
30 and analyzed in the linear trap using the rapid scan mode. Fragment scan where recorded 
with a fixed first mass of 110 m/z. Only precursors with charge states 2-7 and a signal intensity over 
5000 where selected. Already fragmented ions where put onto a dynamic exclusion list for 25 
seconds with an exclusion width of 10 ppm. Monoisotopic precursor selection was activated and 
the instrument was operated in top speed mode with a cycle time of 3 seconds. Peptide 
separation was achieved by RP-HPLC on C18 column (150 mm x 75 ?m, 1.9 ?m, Reprosil pure C-
18 AQ, 120 ? (Dr. Maisch GmbH)). Column temperature was 50°C. Samples were separated over 
90 minutes with a mixture of solvent A (0.1% formic acid in H2O), solvent B (0.1% formic acid in 
ACN) and a flow rate of 300 nl/min, applying the following gradient table: 5-22% solvent B in 79 
min, 22-32% B in 11 min. Column was cleaned after the run by 32-95% B in 2 min, hold 95% for 10 
min prior to re-equilibration with initial conditions. 
 
LABEL-FREE QUANTIFICATION AND PROTEIN QUANTIFICATION USING PROGENESIS 
The raw files from the mass spectrometer were loaded into ProgenesisQI for Proteomics (v.3.1). 
Before the automatic aligning, the loading and the wash phase of the gradient were masked for 
peak picking, the aligning reference was chosen as such where the most features could visually 
be seen. From each Progenesis peptide ion (default sensitivity in peak picking) a maximum of the 
top five tandem mass spectra were exported using charge deconvolution and deisotoping 
option at a maximum number of 200 peaks per MS/MS. The Mascot generic file (.mgf) was 
searched with Mascot Server v.2.5.1.3 (www.matrixscience.com) using the parameters 10ppm 
for precursor ion mass tolerance, 0.6 Da for fragment ion tolerance. Semi-Trypsin for the hydrogel 
portion of the sample and Trypsin for the cell lysate was used as the protein-cleaving enzyme, 
two missed cleavages were allowed. Carbamidomethylation of cysteine was specified as a fixed 
modification, and oxidation of methionine, and N-terminal acetylation of proteins were selected 
as variable modifications. 
Searched was a forward and reversed human database (downloaded on 18/04/2013 from 
uniprot) concatenated to 260 known mass spectrometry contaminants in order to evaluate the 
false discovery rate using the target-decoy strategy.64 
The mascot result was loaded into Scaffold v4.2.1 and filtered for 5% FDR on peptide level and 
10% FDR on protein level using protein cluster analysis. The Scaffold spectrum report was exported 
and loaded into ProgenesisQI.  
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In the experimental design, we used a between group analysis where 10 relevant experimental 
designs were generated. The four treatment groups were all compared to the negative control 
(4 experimental designs) and to each other (6 experimental designs). Each of the groups had 
four sample repetitions. The signal intensity was normalized by the FXIII signal, which was equally 
present in all the samples. 
For quantification, we assessed all proteins identified with at least 2 features and calculated 
individually for each group the average of the normalized abundance from the 3 most intense 
peptide ions of each protein group.65 This normalized quantitative protein abundance was further 
transformed using hyperbolic arcsine transformation prior to statistical testing with the parametric 
t-test. The visualization was done in R environment, where the libraries ggplot2 (v.2.2.1) and gplots 
(v.3.0.1) were used to generate the volcano plots and heatmaps.66,67 
Finally, an over-representation analysis (ORA) was done using WebGestalt 2017 on-line toolkit 
(Webgestalt.org) enabling the comparison of two sets of genes.68-70 Homo sapiens (hsapiens) was 
set as the organism of interest and geneontology as the functional database class. 
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5.4 _ RESULTS 
 
5.4.1_ PROTEOMICS TO DETECT ECM PROTEINS PRESENT IN 3D SYNTHETIC PEG HYDROGELS 
OVEREXPRESSION OF MATRISOME PROTEINS IN HYDROGEL EXTRACT 
3D cultured cells secrete their own ECM into a surrounding biomaterial, which results in the 
modification of their own microenvironment71. In this work, we aimed at investigating if cell-
secreted ECM components can be directly analyzed from 3D cell cultures. Hence, we cultured 
BM-MSCs for two weeks in earlier described, fully defined synthetic PEG hydrogels (Figure 5.1).29 
After gel digestion by trypsin followed by separation of cells and residues by centrifugation, we 
compared the protein profiles of the separately analyzed cell lysates and hydrogel portions of 
the same culture. 
All the data derived from Progenesis analysis. PEG hydrogels that underwent the same procedure 
but did not contain cells were taken as control condition for protein identification. Proteins 
passing our filter criteria described in the materials and methods part were considered for further 
analysis. Coagulation FXIII and Serum Albumin were the only proteins detected in gels without 
cells, originating from the culture media and the gel polymerization process. 
 
 
 
Figure 5.1. Schematic of the experimental procedure. The cells are encapsulated in a PEG gel, which is 
polymerized in a 96-well plate. Cell culture media with or without treatment is added to the well for the time 
of the experiment. At the end, the medium is replaced by Trypsin to digest the gel. Centrifugation permits the 
retrieval of the supernatant with the partly digested proteins fractions. Trypsin is added to the supernatant in 
order to obtain peptides. These are then prepared and run in the mass spectrometer. The cell fraction is 
lysated and  protein digestion and mass spectrometry is also run on those samples. 
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The analysis identified 133 proteins in the gel embedding the BM-MSCs, with a protein false 
discovery rate (protFDR) estimated at zero because of the absence of decoy proteins. From 
those 133 proteins, 33 matrisome proteins were identified (24.7% of total protein count). 19 (14.2%) 
were core-matrisome and 14 (10.5%) were matrisome-associated proteins (Figure 5.2A). From the 
total signal volume detected, 37% and 13% were signal volume from the core-matrisome and 
matrisome-associated proteins (Figure 5.2B). Besides those matrisome proteins, proteins with 
cytoplasmic origin were detected as well. Their presence is the result of cell excretion and cell 
content leakage caused by a) apoptosis induced cell lysis during the cell culture process or b) 
cell lysis during sample preparation. In comparison, the analysis on the cell lysate identified 869 
proteins, from which only 7% were core-matrisome (3%) or matrisome-associated (4%) proteins 
(Figure 5.2A). The same tendency was observed for the total signal volume where 17% and 5% 
originated from the total volume of matrisome proteins (Figure 5.2B). 
 
In order to verify that the matrisome proteins found in the supernatant fraction was representative 
of the cell environment and not of the cell lysate, we performed an ORA analysis of the two data 
set. The ORA of the identified proteins against the total protein coding human genome showed 
a 8.79 fold enrichment over the expected value in extracellular structure organization in the 
hydrogel fraction. This was not the case in the cell lysate fraction where the GO term “Extracellular 
structure organization” was not present in top 10 enriched categories. In summary, cell lysate and 
hydrogel fraction show significant different protein profiles. The hydrogel fractions are highly 
enriched in matrisome and matrisome-associated proteins in contrast to cell lysates, which 
indicates that this technique can be used reliably to identify the proteins produced by BM-MSCs 
cultured in PEG hydrogels.  
 
 
Figure 5.2. Number of proteins and ratio of total signal volume for each 
protein group depending on the origine (hydrogel or cell lysate digest). In 
black, the core matrisome proteins, in grey the matrisome-associated ones 
and in light grey the rest. A) Ratio of the number of core matrisome, and 
matrisome-associated proteins to the total amount of proteins detected. B) 
The ratio of the protein signal volume compared to the total signal volume. 
Proteomics 
89 
BM-MSCS ECM SIGNATURE IN PEG HYDROGELS 
From a bioengineering point of view, the composition of the ECM deposited, which likely replaces 
and furnishes the PEG bulk, is of great interest. Since the ECM directs the behavior, the presence 
or absence of one or another ECM component could potentially modify bioactivity. We here list 
the core matrisome and matrisome-associated proteins found after 20 days in serum-free culture 
media independently of the treatment. The proteins are divided into the core matrisome formed 
by collagens, glycoproteins and proteoglycans and the matrisome-associated proteins excreted 
by the cells (Table 5.1). Only the proteins identified with more than 2 peptides were taken into 
account. None of those proteins were in the gels without cells, which ensures that the proteins 
detected did not originate from the cell culture media. 
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Gene symbol Protein name 
Collagens  
COL1A1 Collagen 1 ?1 
COL1A2 Collagen 1 ?2 
CO6A1 Collagen 6 ?1 
COL6A2 Collagen 6 ?2 
COL6A3 Collagen 6 ?3 
COL11A1 Collagen 11 ?1 
COL12A1 Collagen 12 ?1 
COL14A1 Collagen 14 ?1 
Glycoproteins  
FN1 Fibronectin 
FBLN1 Fibulin-1 
TNC Tenascin 
THBS1 Thrombospondin-1 
THBS2 Thrombospondin-2 
POSTN Periostin 
TGFBI Transforming growth factor-?-induced protein ig-h3 
AEBP1 Adipocyte enhancer-binding protein 1 
LRG1 Leucine-rich ?-2-glycoprotein 
Proteoglycans  
HSPG2 Heparan sulfate proteoglycan 2 
VCAN Versican 
Matrisome-associated  
MMP2 72 kDa type IV collagenase 
A2M Alpha-2-macroglobulin 
ANXA1 Annexin A1 
ANXA2 Annexin A2 
ANXA5 Annexin A5 
ANXA6 Annexin A6 
F13A1 Coagulation factor XIII A chain 
F13B Coagulation factor XIII B chain 
LGALS1 Galectin-1 
HPX Hemopexin 
LOXL1 Lysyl oxidase homolog 1 
P4HA2 Prolyl 4-hydroxylase subunit ?-2 
HTRA1 Serine protease HTRA1 
SERPINH1 Serpin H1 
 
Table 5.1. Core matrisome and Matrisome-associated proteins expressed by BM-MSCs and identified in the 
hydrogel portion.  
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5.4.2 _ INFLUENCE OF GROWTH FACTOR EXPOSURE ON ECM DEPOSITION 
A major advantage of the approach presented here resides not only in the identification of the 
proteins composing the ECM but also in the possibility to quantify their relative abundancy. This 
data is exploited in this study by investigating the influence of growth factor treatments in the 
differential production of ECM proteins by BM-MSCs in 3D PEG hydrogels. The GFs of choice were 
administered separately either throughout the total 20 days of the assay or exposed sequentially 
during the first and then the last 10 days of the experiment. Figure 5.3 shows the two stimuli for the 
4 treatments of choice in addition to the negative control. Two treatments had either TGF?1 or 
PDGF/EGF throughout the 20 days of culture. The two other treatments exposed TGF?1 and 
PDGF/EGF stimuli sequentially, in different orders. Due to the distinct nature of the stimuli 
delivered, the ECM composition pattern is expected to vary with the different treatments. 
 
The heatmap in Figure 5.3 represents the protein abundancy as an inverse hyperbolic sine 
transformation of the protein signal intensity. It shows the intensity for all four replicates of each 
group. The 33 matrisome proteins were present in all the groups. Unsupervised clustering allows 
clear distinction between treated and untreated samples, which is clearly visible on the 
heatmap. Clustering also shows a separation in the second hierarchy of the dendogram, 
attesting of a difference between the groups exposed either to PDGF/EGF or to TGF?1 in the first 
10 days. Furthermore, all the treatments are grouped, besides one exception where one sample 
of TGF?1 - PDGF/EGF is grouped with the TGF?1 - TGF?1 treatment. This indicates low variance 
within the treatments, which means good reproducibility of the experiments. 
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Figure 5.3. Heatmap representing asinh (signal intensity) for every matrisome protein detected. The 
dendogram shows clustering of the groups by the signal intensity of the protein set. The color key and 
histogram represents the color assigned for each intensity level and the number of events for each of those 
intensities. The treatment groups are represented by a dotted filling for TGF?1 (100ng/ml) a black filling for 
PDGF and EGF (100ng/ml each) and white for no treatment. Each group is composed of two sequential 
treatments represented by a left half-circle for the first 10 days and a right half-circle for the last 10 days of 
treatment. 
 
INFLUENCE OF GROWTH FACTOR TREATMENT VERSUS NO TREATMENT 
Our results clearly show that the protein abundance of cells grown without GF stimuli is much 
lower in comparison to cells treated with GF. A deeper statistical analysis comparing each 
treatment group to the negative control can quantify the increase or decrease of specific 
protein abundances, which could be a valuable tool to favor one treatment over another 
depending on the ECM composition wished. The heatmap in Figure 5.4A represents the base two 
logarithmic fold change in protein expression from each treatment compared to the non-
treatment group. Figure 5.4B represents all 33 matrisome and matrisome-associated proteins as 
a volcano plot of significance versus fold change for each of the treatments compared to the 
negative control. We considered an expression to be significantly different when the raw fold 
change exceeded 2 (i.e. Log2(fold change) >1) and if the p-value was smaller than 5% (i.e. –
Log10(p-value) <1.301).  
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The first observation is that 29 out of the 33 proteins have at least one treatment providing 
significant difference compared to the negative control. Indeed, every protein is present at least 
once in the significant (above horizontal grey dotted line) and differential (left or right from 
vertical grey dotted lines) expression panels. The 4 exceptions are LRG1, HPX, F13A1 and F13B 
(Figure 5.4, white box with black borders) which have no treatment significantly influencing their 
abundance. Looking in more details, the results provide clear input on the effect of each 
treatment on every protein. In total, 17 proteins are significantly influenced by all the treatments. 
The 12 other proteins have specific treatments providing significant change in protein 
abundance compared to the negative control. These are COL12A1, COL1A1, COL1A2 (Figure 
5.4, blue box), COL6A2, FBLN1, HSPG2, THBS2, VCAN and MMP2, which are influenced by 3 
treatments; COL6A1, by 2 treatments and finally A2M (Figure 5.4, yellow box) and P4HA2 (Figure 
5.4, blue box) by one treatment out of the 4. 
  
Interestingly, growth factor exposure does not have only an upregulating effect on ECM 
production. Indeed, 3 proteins are present in lower abundance in some treatment cases 
compared to the negative control. Those proteins are marked with a blue box and their 
downregulation is shown by their presence on the left side of the vertical grey dotted line. All of 
these 3 proteins have a specific treatment downregulating their abundance. COL1A2 is 
downregulated when only PDGF/EGF is administered, while in the case of P4HA2, this happens 
when only TGF?1 is present. Finally, COL14A1 (Figure 5.4, blue box) can also be downregulated 
by exposing cells to TGF?1 in the first part of the experiment. Interestingly, this tendency is inversed 
and COL14A1 is upregulated in the two other treatments. Similarly, besides when treated only 
with PDGF/EGF, like mentioned before, the production of COL1A2 is boosted when adding TGF?1 
first. These observations highlight the importance of treatment choice for given proteins. The 
significant down- and upregulation of COL1A2 and COL14A1 depending on the treatment are 
proofs of the differential expression triggered by growth factors, which can be determinant in the 
fabrication and reproduction of cellular microenvironments. 
 
PROTEIN ABUNDANCE DEPENDING ON THE TREATMENT 
In addition to studying if growth factor treatments have stimulating or inhibiting effects in ECM 
production compared to no treatment at all, it might be of interest to analyze variations between 
those treatments. This could help experimenters to choose culture conditions favoring higher or 
lower amount of certain type of proteins and direct specific ECM production. A first valuable 
information is to find the treatment favoring the larger number of proteins. By counting the 
number of proteins, we observe that the treatment with PDGF/EGF followed by TGF?1 stimuli 
results in a total of 26 proteins present in significantly higher abundance compared to the 
negative control. This number drops to 23 for the PDGF/EGF – only groups, 24 for the TGF?1 – only 
group and 22 for TGF?1 followed by PDGF/EGF. Hence, PDGF/EGF followed by TGF?1 turned out 
to be the treatment stimulating the larger number of different proteins. 
In our premises, we hypothesized that a combination of GF might optimize ECM protein 
deposition thank to the complementary effects of TGF?1, PDGF and EGF. To verify this idea, we 
compared the two groups composed of one stimulus only (TGF?1 or PDGF/EGF) with the two 
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groups alternating those stimuli. Quantitative analysis shows that 7 proteins (COL11A1, TGFBI, 
AEBP1, COL12A1, ANXA5, ANXA6, and LOXL1) are in significantly higher amount when alternating 
GFs than when giving any of the unique GF treatments. In contrary, COL1A2, COL14A1 and MMP2 
deposition is at its maximum when using one GF only. This highlights one more time the effect of 
the treatment choice on whether or not a protein is in higher quantity than in the negative 
control. 
 
To conclude, we compared the effect of the sequence of GF exposure in the two treatments 
where both stimuli where administered. It is interesting to notice that, when there was a significant 
difference between those two treatments, the choice of PDGF/EGF before TGF?1 always resulted 
in higher protein amount. As an example, COL12A1 and LOXL1 (Figure 5.4, red box) have a 
significantly higher upregulation when exposing to PDGF/EGF stimuli than the opposite. This point 
the important role not only of the combination of diverse bioactive stimuli but also from the 
sequence in which they are exposed. 
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Figure 5.4. Comparative analysis of each treatment versus the negative control. A) Base 2 logarithmic fold 
change of protein expression for each group compared to the untreated group. The color key and 
histogram represents the color assigned for each change level and the number of events for each of those 
fold changes.  B) Volcano plot to show the significance versus the fold-change in expression for the ECM 
proteins identified. The red horizontal line represents the threshold above which the expression is significantly 
different. The red vertical lines represent the threshold for 2 fold logarithmic over-(right) and under-(left) 
expression. 
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5.5 _ DISCUSSION 
In this work, we successfully studied ECM deposition of cells immobilized in 3D synthetic hydrogels 
with an unbiased proteomics approach. This method enabled to tackle important limitations 
encountered with more classic approaches. A critical factor that contributed to the success of 
this study was the use of materials that did not generate background signal. The use of synthetic 
PEG hydrogels as cell carriers was perfectly suited to this application. The absence of protein, 
besides FXIII as the polymer linker enzyme, ensured no contribution of the cell carrier to the 
peptide signals detected by the mass spectrometer. In addition, the biologically inert 
characteristics of this material discarded the possibility of inherent cell stimulation. The use of 
alternative materials like for example Matrigel™ would completely jeopardize the possibility to 
detect proteins produced by cells. Indeed, Matrigel™ is a naturally derived material widely used 
in cell culture in vitro but has been shown to be made of hundreds of proteins.72 Proteomics 
analysis in these conditions is technically possible but the inherent presence of all these proteins 
would generate an important background signal originating from the gel itself as well as from the 
cell production stimulated by the proteins contained in the gel. In result, the peptides detected 
would be impossible to be assigned to the sole induction by the biological stimuli provided by 
the experimenter. Moreover, the use of FBS-free culture media prevented the contamination of 
the cell environment with proteins present in FBS. It also avoided the contribution of biological 
stimuli contained in the medium, which could have provoked alternative signals not originating 
from the treatment added. 
   
To demonstrate our approach, we first proved that we could selectively analyze the environment 
created by the cells themselves in 3D synthetic hydrogel cultures. Indeed, the ORA and the signal 
distribution analysis showed a strong enrichment of ECM proteins when analyzing only the 
hydrogel component of the samples. This contrasted to the analysis of the cell lysate where ECM 
proteins were not overexpressed compared to theoretical expected expression rates. This did not 
only show that our samples contain mainly ECM proteins but also excluded the hypothesis that 
the proteins originate from the cell lysate residues. 
 
The list of identified core-matrisome proteins was comparable to the results shown previously in 
2D BM-MSC cultures, which supports the claim that our method can reliably be used in 3D.36 The 
majority of the proteins were detected in all conditions with changing abundancy. For example, 
FN1 was present in all conditions, including in the negative control. This protein is known to be 
present in almost all tissues and its deposition happens at very early stages in ECM production 
and plays a crucial role in the initiation of matrix assembly.73 Its ability to bind growth factors, 
including PDGF and TGF?1, could modulate the availability of those biological cues and possibly 
explain biological processes.14 The matrisome-associated protein excretion was mainly 
composed of proteases involved in tissue remodeling and wound healing (MMP2, HTRA1, ANXA), 
protease inhibitor (A2M), Collagen binding and/or catalysis (LOXL1, P4HA2, SERPINH1) and cell 
proliferation (LGALS1). As expected, coagulation factor XIII was also present since this enzyme 
was used for PEG polymerization. 
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Besides the identification of a relevant set of ECM proteins in all samples, we could also observe 
differential protein composition in the hydrogels as well as significant fold change variations in 
protein abundance depending on the treatment provided. This outcome suggests that the label-
free quantification method can be of high relevance when aiming to reproduce an ECM with 
precise composition. For example, COL1A1 was only upregulated in the presence of TGF?1 and 
the same tendency is observed for COL1A2, which is significantly downregulated in the absence 
of TGF?1. This observation corroborates with previous observations in literature, which attributes 
the production of COL1 to the effect of TGF?158-60. Hence, the addition of this growth factor in 
cell culture media appears to be a requirement to maximize COL1A1 deposition. This can be of 
relevance when developing tendon, dermis, bone, cartilage or sclerotic tissue mimics, where 
COL1 is preferentially synthesized.74 
 
Another interesting observation resulting from this study is the opposite effect that some treatment 
have. This is the case for COL14A1, which was significantly upregulated in the cases where 
PDGF/EGF stimuli was delivered first and downregulated when TGF?1 was given at the beginning. 
This protein is reported to act as a regulating protein in fibrin growth in developing tendon 75 and 
is present in most of the COL1 containing tissues.76 This could indicate a possible interaction 
between those two proteins and speak in favor of a treatment promoting both proteins instead 
of just one. However, our results also suggests that some treatments have a stimulating effect on 
some proteins while having an inhibiting effect on others. Interestingly, this is the case for those 
two proteins mentioned above, COL14A1 and COL1. Our data show that a simultaneous 
upregulation of COL1A1, COL1A2 and COL14A1 cannot be done with the treatments 
administered. Treatments increasing COL1A1 and COL1A2 both inhibit the production of 
COL14A1. In opposition, upregulation of COL14A2 is accompanied by either downregulation of 
COL1A2 or upregulation of COL1A1. Hence, upregulation of the three proteins is, based on our 
results, not possible. Depending on the composition wanted, this could be a critical information 
towards the addition or not of a specific stimulus and to provide awareness about the 
compromises imposed by the choice of a treatment. 
 
Finally, our analysis enabled to highlight the importance of the combination of growth factors 
and the sequence in which the cells are exposed to them. COL11A1, TGFBI, AEBP1, COL12A1, 
ANXA5, ANXA6, and LOXL1 expression was upregulated when altering the treatments after 10 
days and overall protein production was significantly increased when PDGF/EGF were 
administered first. This observation could be used in the future for approaches where the 
temporal control of signal presentation is addressed to explore the 4th dimension of tissue 
engineering. For example, click, clip and caging strategies enable to selectively bind, remove or 
make bioactive molecules available in a time-controlled manner.77 Alternatively, the release of 
growth factors could be controlled by incorporating biological signals to the PEG backbone 
containing cleavage motifs with different cleavage kinetics. This way, growth factors are 
released by proteinases produced by the own cells and the release kinetics is controlled by the 
enzyme affinity of the cleavage motifs specific to each growth factor added.  
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CONCLUSION 
The careful analysis of the protein level, depending on the treatment, enables the deciphering 
of the ECM replacing the PEG hydrogel scaffold, after a time in culture and provides a relevant 
method for building on-demand customized cellular environments. We showed that state of the 
art proteomics analysis tools could be used to analyze the complex environment deposited by 
the cells in relevant 3D platforms. This could be helpful for mimicking tissues as faithfully as possible 
for in vitro studies, drug screening and discovery platforms. Additionally, deciphering the native 
environment and directing the reproduction of it could provide in vivo implants with an 
environment that enhances the survival of the implanted cells and consequently improves their 
action on the host tissue. 
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CHAPTER 6 _ CONCLUSION  
 
 
 
 
6.1 _ GENERAL DISCUSSION 
The essence of this thesis was to develop a strategy for the healing of fetal membranes and 
prevent their rupture after fetoscopic interventions. To achieve that long-term goal, we worked 
on two very different aspects. On one hand, we developed a medical device for the minimal 
invasive delivery of injectable materials. On the other hand, we worked on the development of 
healing promoting materials as well as on methods that enable the assessment of their biological 
functions in a more basic research approach. In total, our work resulted in one peer reviewed 
publication, two manuscripts to be submitted in 2017, two patent applications and the funding 
of three grants. 
 
 
6.1.1 _ DEVICE FOR PRECISE DELIVERY OF SEALING MATERIAL ON AN EX VIVO MODEL 
The goal of objective 1 was to develop a minimally invasive implantable device and to test its 
functionality on a model reproducing fetal membrane injury ex vivo. This was described in 
Chapter 2. As a result, we managed to design and produce a prototype respecting all the 
requirements in terms of size and functionality to be compatible with the fetoscopic instruments 
used in the clinics. We showed that nitinol covered with a Degrapol® mesh could reliably be 
crimped into the accession catheter, pushed inside a cavity and deployed automatically into 
the shape configuration set. We then demonstrated that this umbrella-shaped receptor could 
efficiently be used as a tool for gathering any type of materials at the precise site of membrane 
defect. Indeed, the use of multiple glues (one component cyanoacrylate glue, two components 
fibrin and mussel glue), indicates that our device is adapted to materials of different natures. Our 
choice for testing mussel glue in wet conditions was motivated by recent evidence of its efficient 
adhesion ability.1-4 Despite the low adhesion strength of mussel glue, its gluing ability was 
confirmed as it retained the receptor at the puncture site in the ex vivo model. However, the 
choice of adhesives is not limited to mussel glue. Alternative gluing materials, whose poor 
application efficiency was a limiting factor in previous studies,5-10 could take advantage of our 
device to be applied precisely at the defect site. 
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Next, we established an ex vivo replica with realistic physiological conditions, which enabled us 
to demonstrate the feasibility of our method on a clinically relevant model. The mechanical 
stability conferred by the multiple porcine and human tissue layers highlighted the importance 
of the quality of the model for a reliable assessment of our method. The watertight installation of 
the model enabled the recreation of a wet environment and allowed for an increase in fidelity 
towards the analogy with a real surgical set-up. In addition, we took advantage of our model 
system to add external inlets which enabled image retransmission from the inside of the amniotic 
cavity replicate for direct visual feedback. 
 
As a result of our work, we submitted a European patent application on this technology on 
September 29th 2016. The potential of such technology was acknowledged by multiple instances 
confirming the potential translational impact that it could have on thousands of foetuses and 
families around the world. Indeed, a project proposal for further development was granted by 
the Commission for Technology and Innovation (CTI) and a Swiss National Science Foundation 
(SNF) grant was attributed in October 2016 based on the advances realized during this project. 
Further research will definitely help the domain of fetal surgery that suffers from the debilitating 
high rate of preterm birth and would open a new horizon in minimally invasive surgery by 
permitting interventions for indications which have been ignored until now. 
 
 
 
6.1.2 _ HYDROGEL PLATFORMS TO STUDY HEALING INDUCING CUES IN VITRO 
The specific objective of the second part of the project was to engineer healing promoting 
materials and to establish platforms that allow in vitro study of cellular response to biological 
cues. 
 
STABLE 3D GROWTH FACTOR GRADIENTS 
In the article presented in Chapter 3,11 we reported MSC activation upon presentation of a 
gradient of immobilized PDGF. We first verified the activity of the GF on the cells in a microtissue 
assay and observed concentration dependency of migration, proliferation and morphology. 
Next, we took advantage of electrochemical inhibition of PEG polymerization to reproducibly 
create channels inside PEG hydrogels populated with MSCs.12 We used these channels as a 
source of GF from which the biological cues diffused and bound by affinity to the surrounding 
PEG matrix. The PDGF gradient resulting from this process enabled us to create a synthetic 
platform with an organized 3D complexity and assess the spatially differential effects on MSC 
migration and morphology.11 A large number of studies in 2D and 3D cell cultures focused on 
the formation of gradients in vitro.13-19 They have all been motivated by the interest in recreating 
a biological process present in nature and responsible for cellular regulation in developmental 
biology, wound healing and tissue homeostasis.20,21 In our work, we presented for the first time a 
stable gradient formed by growth factor immobilization in a synthetic 3D PEG environment. 
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SCREENING PLATFORM FOR CELL INVASION  
In Chapter 4, we concentrated on the development of alternative platforms which allowed us 
to address the migration-inducing effect of those biological cues. As a matter of fact, migration 
is one of the first cellular processes in the wound healing mechanism,22 which, in the context of 
this thesis, is a characteristic required for a healing inducing material. Previous studies have 
shown how migration could be assessed using pre-casted collagen or hyaluronic acid gels.23,24 
However, those materials have the disadvantage to carry signals inherent to their natural origin. 
 
Here, we took once again advantage of the electrochemical inhibition of PEG polymerization 
to fabricate a whole 96-well plate of hydrogels possessing a stiffness gradient. Those gels had the 
property to be very soft at the surface, which enables hydrogel formation prior to cell seeding 
without losing the 3D aspect granted by PEG hydrogels. We report how this resulting platform 
can be used to quantify cell migration into the gel in response to biological cues in a 96-well 
plate. For that, we set our focus on developing scripts for the automation of confocal image 
acquisition of the 3D gel stack and data processing for the numerical conversion of signal into 
quantifiable input. In addition, we developed an algorithm enabling the correction of gel 
irregularities for reliable analysis of cell invasion. As a result, we succeeded in analysing a large 
number of samples in parallel in a very limited amount of time. This allowed us to test multiple 
growth factor concentrations in a statistically relevant number of replicates, which can be of 
importance for the use in larger scale studies aiming to address cell invasion level in synthetic 
hydrogels in vitro. 
 
WOUND MODEL FOR CELL RECRUITMENT 
Next, in Chapter 5, we developed a wound model by creating a channel in hydrogel cell culture 
and utilized it to test healing promoting materials. In this case, growth factor was delivered inside 
the wound mimic by the injection of a PEG hydrogel carrying biological cues inside the channel. 
This hydrogel played the role of a healing material and was designed to enable cell penetration 
inside of it. The recruitment potential of the growth factor was then evaluated by measuring the 
concentration of cells invading and colonizing the healing hydrogel. This platform confirmed the 
increased recruitment rate when PDGF was present compared to the case when no PDGF was 
delivered. Hence, the platform proved to be perfectly suited for the study of the recruitment 
inducing capacity of a healing material on an in vitro wound model. 
 
QUANTITATIVE PROTEOMICS TO STUDY ECM SYTHESIS 
The last objective, which is presented in Chapter 6 was motivated by the need to gain 
knowledge about deciphering the microenvironment created by cells cultivated in 3D synthetic 
hydrogels. This rationale was supported by decades of research that sought to elucidate the 
structure of body tissues. More specifically to our case, the components of fetal membranes 
have been the topic of several published works that highlighted the contribution of each 
extracellular-membrane protein to the structural stability of the membranes.25,26 This interest 
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became even more relevant when recent discoveries reported that those proteins do not only 
have a structural function but that they also have a central function in regulating biological 
signals in the complex cellular environment. Indeed, ECM proteins have been shown to 
sequestrate growth factors27-31 and send biological signals to direct cell fate and behaviour.32-38 
Thus, the faithful reproduction of the ECM environment is a determining factor when aiming to 
mimic native tissues in vitro or when engineering healing materials directing the regeneration of 
a specific tissue. 
 
Throughout this work, we made use of growth factors as biological signals and potential cues 
inducing the healing process. Based on previous studies that show growth factor dependency 
of specific ECM protein synthesis,11,22,39-42 we aimed to present a way to identify the proteins 
produced and deposited in synthetic PEG hydrogels when cultivated in the presence of growth 
factors. This was successfully done by taking advantage of mass spectrometry analysis and label 
free quantification to address the variation in ECM components depending on the treatment 
provided. Our data displayed clear variations after 20 days in culture. Treating cells with 
PDGF/EGF or with TGF?1 resulted in a set of ECM proteins present in different quantities. In 
addition, we could also attribute protein abundance to the order of growth factor delivery, 
highlighting once more the importance in the choice of the cues as well as the order in which 
they are presented. 
In summary, we managed to present a method that enables the tracking down of the exact 
ECM components of a newly produced environment by, in opposition to RNA sequencing, 
detecting signals in a protein level. 
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6.2 _ FUTURE OUTLOOK 
DEVICE OPTIMIZATION 
The medical device showed clear potential for the future use, however, several design 
parameters will need optimization to reach the clinics. First, shape and size of the umbrella-
shaped retainer will need to be adapted to optimize its mechanical properties. Despite its 
workability, it lacks in pulling resistance, which is needed for the reliable placement of it by the 
physician without visual control. Second, the handling piece used by the surgeon to implant the 
receptor must be developed following industrial production and regulations requirements. 
Finally, the choice of gluing material has to be made by preferentially testing various candidates 
within existing biocompatible adhesives. Their ability to bind the receptor in a stable manner, in 
wet conditions will be key elements for its adoption. The weak adhesion strength of the two 
components glues also indicates the need for improvements. The addition of a mixing device at 
the distal end of the device, adjustment of glue viscosity and speed of application can 
potentially play a determinant role for optimal membrane defect stabilization. All those elements 
can be tested on the models set out in Chapter 2. 
In addition, cyclic pressure variations could be applied by adapting the models set out in 
Chapter 2 to simulate contractions and assess the stability of the implanted materials in dynamic 
conditions.2,43 The adhesive strength of those glues will be tested in combination with multiple 
materials covering the nitinol receptor backbone. For example, ePTFE or silicone mesh will be 
tested in combination with fibrin glues or cyanoacrylate-based adhesives. Those materials are 
biocompatible and have the advantage of already being used in clinical applications.44-48 
 
INJECTING HEALING-INDUCING MATERIALS 
The device was made to enable the application of any type of injectable materials. In a long-
term approach, sealing materials might be replaced by bioactive materials stimulating tissue 
healing at the site of application. Thus, the establishment of platforms presented in Chapters 3-5 
to address the effect of bioactive cues on cellular behaviour is highly relevant in the context of 
tissue healing. In the next steps, those platforms will be used to investigate the healing processes 
of a myriad of bioactive signals on the precise cell types of interest. In this precise case of fetal 
membrane healing, cells harvested from fetal membranes will be cultivated first on the 96-well 
hydrogel gradients plate to quantify the activation potential of growth factors. Thanks to the 
automation of production until data analysis, an important number of samples will be analysed. 
Besides the analysis of cell invasion, the production of ECM will be assessed on the same assay. 
Since the proteomics approach only requires digestion of the sample, it could be done on the 
same hydrogel gradients. This way, one could make a direct parallel between invasion index 
and ECM production. 
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Moreover, development of new approaches to control the immobilization of biological cues in 
synthetic hydrogels allows us to illustrate a vast range of possibilities for controlling the exposure 
of growth factors to cells. For example, it has been shown that ligands can have different binding 
affinities.49 This characteristic can be used to bind multiple growth factors each to one ligand 
and thus, varying the availability of those cues thanks to their different affinity. Alternatively, one 
can think of covalently binding growth factors to the hydrogel backbone and linking it to a 
degradation motif, which, in turn, can also be tuned to vary its degradation kinetics.50 This way, 
one can engineer materials having successive release and presentation of growth factors. The 
platforms resulting from objectives 2 and 3 are perfectly adapted to this type of study. It would 
allow the study of the effect of growth factor binding and successive release on the activation 
potential and on the specific ECM protein production. This could be used as a real platform for 
screening purposes by tailoring the 4th dimension of complex biomaterials.51,52 More specifically 
for our project, the type, the concentration and the successive presentation of growth factors 
could be studied to optimize cell recruitment and production of specific ECM proteins like 
Collagens II, III, V, Laminin and Fibronectin, which form the core structural composition of amnion. 
Put together, these elements are the necessary tools for the development of the ideal material 
inducing the healing of fetal membrane defects by producing the native tissue components. 
This will ultimately need to be tested and verified in combination with the application device on 
big animal models (Figure 6.1 red). 
 
To conclude, each chapter resulted in a significant contribution to their respective field by 
bringing novelty on both the medical technology side and on the synthetic tissue engineering 
domain. Together, all these elements could be combined in the future to engineer injectable 
smart healing materials that specifically trigger healing processes, going one step towards the 
complete regeneration of tissue defects. 
 
Figure 6.1. Schematic representation of future possibilities enabled by the achievement of 
objectives 1, 2 and 3. The application device, combined with the assessment of healing 
process like cell activation and ECM production can result in the delivery of smart materials 
to efficiently regenerate tissue defects.  
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